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“Le savant n'est pas l'homme qui fournit de vraies réponses ;  
c'est celui qui pose les vraies questions." 
“Scienziato non è colui che sa dare le vere risposte, ma colui che sa porre le giuste domande.” 
 
- Claude Lévi-Straus 
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LIST OF ABBREVIATIONS 
2.5D  two and one-half-dimensional 
2D two-dimensional 
3D  three-dimensional 
3R reducement, refinement, replacement 
AB  Alcian Blue 
Ab  antibodies 
Abs absorbance 
AEC1 Alveolar Epithelial Cell type I 
AEC2 Alveolar Epithelial Cell type II 
ALI  air-liquid interface 
AP  Apical 
APC  Antigen Presenting Cell 
APC  allophycocyanin 
AQP3 Aquaporin-3 
BALT Bronchus-Associated Lymphoid Tissue 
BC Basal cell 
BE Bronchial Equivalent  
b-FGF basic-fibroblast growth factor 
BL  Basolateral 
BMe Basement membrane 
BM-MSC Bone Marrow mesenchymal stem cell 
BSA Bovine Serum Albumin 
C. difficile Clostridium difficile 
CBC  Crypt Base Columna 
CC Ciliated Cell 
CCSP Clara Cell Secretory Protein 
CD* Cluster Differentiation 
CDI  C. difficile disease 
CDI, CDAD (C. difficile associated disease) 
CFSE  Carboxyfluorescein succinimidyl ester 
ChoP phosphorylcholine 
CK* Cytokeratin (n°) 
Cl-C Club Cell 
COPD Chronic Obstructive Pulmonary Disease 
CRP C-reactive protein 
CZ  conducting zone (of respiratory tract) 
DAPI 4',6-diamidino-2-phenylindole 
DC Dendritic Cell 
DC-BE Bronchial Equivalent  with Mesenchymal Stem Cells 
DPBS  Dulbecco's phosphate-buffered saline 
EC  Enterocytes 
ECM  Extra Cellular Matrix 
EE Enteroendocrine 
EGF Epithelial Growth Factor 
EnO  Enteroids 
ENR  EGF, Noggin, R-spondin 
ESC  Embryonic Stem Cell 
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FABP4 Fatty Acid Binding Protein 4 
FITC fluorescein isothiocyanate  
GC Goblet Cell 
G-CSF Granulocyte-Colony Stimulating Factor  
GF  growth factor 
GM-CSF Granulocyte-Macrophage Colony-Stimulating Factor 
GTD glucosyltransferase domain  
Hap Haemophilus adhesion and penetration protein 
HBEC  Human Bronchial Epithelial Cell 
HE Hematoxylin and Eosin (staining) 
Hib Haemophilus influenzae type B 
HLF  Human Lung Fibroblast 
HMW High Molecular Weight (adhesin) 
HPV  Human Papillomavirus – 16 
HSC  Hematopoietic stem cell 
HTS  High throughput screening 
HUVEC Human Umbilical vein endothelial cell 
IFN-y Interferon gamma 
IGC  Intestinal Goblet Cell 
IHC Immunohistochemistry 
IL- Interleukin- 
IP-10 Interferon gamma-induced protein  
iPSC induced Pluripotent Stem Cells 
ISC Intestinal Stem cell 
ISCC Intestinal Stem Cell Consortium  
ISCT International Society for Cellular Therapies 
ITGa6 Integrin alpha chain alpha 6. 
LL-37 (Cathelicidin antimicrobial peptide) 
LOS Lipooligosaccharide 
Lu-MSC Lung resident Mesenchymal Stem Cell 
Mabs monoclonal antibodies 
MIP-1a Macrophage Inflammatory Protein 
MoDC Monocytes derived Dendritic Cells 
MSC  Mesenchymal stem cells 
MSC-BE Bronchial equivalent  with dendritic cells 
MUC5AC Mucin 5 ac 
MUC5B Mucin 5 b 
NEB  Neuro-epithelial bodies 
NGFR Nerve growth factor receptor 
NHBE Normal Human Tracheo-)Bronchial Epithelial Cells 
NHLF Normal Human Lung (adult) fibroblast 
NTHi Non-Typeable Haemophilus influenzae 
O.C.T. Optimum Cutting Temperature 
OD Optical density  
OMP  Haemophilus outer membrane protein 
PAS  Periodic acid–Schiff  
PBMC  Peripheral Blood Mononuclear Cells 
PC Paneth Cell 
p-DC pulmonary- Dendritic Cell 
PDGFR Platelet-Derived Growth Factor receptors 
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INTRODUCTION 
1 Traditional cell culture models: limits and benefits 
1.1 Mammalian cell lines and primary cells 
Our current knowledge of the molecular basis governing biological processes such as physiology, 
development and pathology, are based on cellular models. A cellular model would be useful to 
simplify complex physiological systems (e.g. organs and tissues) or to standardize a whole-living 
organism to study undiscovered biological mechanisms. The use of ex vivo samples, despite the 
ethical issues, is always linked with the source accessibility of the tissues to be taken out and then 
kept alive until the desired testing. Also the costs of ex vivo testing are a reason to push the demand 
for more accessible models. To address current medical issues and to recapitulate human being 
biology, since the beginning of the 20
th
 century, cell-based models offered advantages enabling 
scientists to observe phenomena inspiring the basis of cellular and molecular biology. Currently, 
cell culture plays its part not only in basic research but are widely used in the majority of 
biotechnology applications (Figure 1). Nowadays mammalian cell cultures are well established 
methods. The traditional 2D cell culture allows to manipulate and to propagate primary cells, 
tumor-derived or virus-transformed cell lines, even stem cells isolated from the human body. At the 
same time the possibility to store cells for years by cryopreservation, is a convenient method 
although a functional impairment may occur after repetitive freeze-thaw cycles. Cell cultures are 
classified as anchorage independent (they live just suspended in a fluid medium) and dependent 
(they require a surface to which they can attach to survive and grow)(Table 1). 
Continuous cell lines are mainly divided by the immortalization step that characterizes them. 
Immortalization derives from a spontaneous transformation event or it is induced by viruses or 
chemicals, otherwise it is mediated by targeted oncogenesis. Inopportunely the immortalization 
process involves phenotypic alteration in a cell. Sub-culturing of primary cells lead to finite cultures 
that present Hayflick limit since after limited number of cell divisions, they will senesce irreversibly. 
Finite cultures maintain several in vivo characteristics, but if passaged over time they tend to 
differentiate and to select for aberrant clones. Until now, thanks to this “flat biology” approach, 
diverse mechanisms have been characterized under carefully optimized in vitro conditions, 
consisting in favorable artificial environment in which added exogenous factors mirror the tissue 
pre-isolation growth requirement. In particular, continuous cell lines offered the advantages to 
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interrogate standardized clonal systems, in comparison with in vivo models that have economic and 
ethical constraints. For example, if the aim of the study is to analyze mitochondria ultrastructure, or 
to study relatively simple metabolic response, cell lines are likely to be exhaustive. However, the 
choice to use in an experiment a cell-line or primary cell based model is not a trivial issue. For 
instance, CaCo2 is a human colon-derived epithelial robust cell-line that can be used for general 
long-term assays, intestinal absorption studies or as colon cancer model. Even though it is possible 
to add defined concentrations of soluble growth factors modulating cell functions, the CaCo2 
phenotype remains significantly different in terms of protein expression patterns, morphology and 
absorptive properties. In addition, cell lines compared to primary/finite cells usually display 
different epigenetic profile, cytokines secretion and plasma membrane markers. On the other hand, 
primary cell cultures better imitate the parental karyotype and the sensitivity to agents, whereas can 
reflect the variability existing in a population. Recently, thanks to the ectopic expression (by means 
of cDNA) of the telomerase activity, responsible to extend telomere lengths and avoid senescence, 
hTERT-immortalized cells were introduced as alternative to classical primary cell culture. 
Confident in the fact that they do not present a genomic instability or great phenotypic changes 
from parental tissue, h-TERT cells offer a good surrogate for biochemical screening, genetic 
manipulation and in vitro HTS. Other advances of using cell lines are represented by the 
exploitation of viral elements in industrial cell engineering: transfection of SV40 large T-antigen 
makes a condition by which the immortalization timing is stopped under temperature control, in 
favor of a quite differentiation; HPV16 E6/E7 gene is able to suppress cell cycle regulators as p53 
and RB, inducing a senescent cell replication. Therefore, despite the risk to generate artefacts, cell 
lines are preferable to avoid a repeated testing of primary cells donors or when primary cells 
isolation and requested total quantity are technically difficult to obtain, time consuming and costly.   
As a matter of fact, after the isolation, any cell loses its interaction with their natural environment. 
The leading change is morphological and could affect the original physiological functions. Actually 
many tissues do not require an aligned mesh of ECM. Indeed some primary normal or cancer-
derived hemopoietic cells are cultured as a homogenous suspension in surrounding culture medium 
that does not extremely differ from blood.  
Apical, basal and lateral surface are very important elements when cell polarity occurs in tissue. 
However, this is true for epithelial but not for most of mesenchymal cells. Substrates used for 
traditional 2D cultures (such as flasks, petri dishes, cell culture plates) are static. Occasionally,  
plastic or glass surfaces may be partially covered by cells (less than 50%), whereas cells that overly 
attach and then spread by breaking their reciprocal contacts are often strongly limited to ~5%. Many 
aspects, varying cellular proliferation and fitness, are controlled by artificial actions that alter the in 
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vivo functions. Here we could do many examples nonetheless it is enough to indicate that just serum 
addition represents a cause of a stronger adhesion and activation of pathway. Substrate stiffness 
deeply contributes to cell fate specification: we have learned that MSCs are influenced by different 
rigidity of the substrate and according to it they follow distinct lineages. In general, in 2D culture 
stiffness parameters like Young’s modulus are considered supra-physiological. Other limitations 
comprise the accessibility to determined drugs, compounds, microorganisms. In fact the third 
dimension missing in 2D culture grants the barrier concept existing in vivo. Soluble molecules that 
are added as tester or sustaining factors for the culture easily diffuse in the medium, quickly 
equilibrate and reach the cells; despite it still needs a strict man-made replacement the contact with 
the cells is unimpeded. Instead, considering the passage of the delivered molecules through in vivo 
structures, the free space they encounter among ECM, the direction of the movement and the ECM 
binding capacity itself are all factors contributing to the 2D cell culture imperfection and weakness. 
Last but not least, in 2D culture it’s hard to preserve the cell genotype because the frequent 
mechanical sub-culturing of cells modify surface receptors and increase senescence, as well a 
functional impairment that is caused by freezing and thawing. For all these reason there’s a 
tendency to upgrade cell model systems in appropriate combinations of more cell types, mixing 
cellular and ECM counterpart in the culture, to test more physiological niches.  
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Type Origin Passages 
Primary culture Tissue, isolation 0-1 
Finite culture Primary cells, subculturing Very limited (adult  tissue) 
20-60 (fetal tissue) 
Continuous  cell line  Finite cultures, spontaneous 
transformation  
Unlimited 
Transformed cell line Tumor Tissue, spontaneous or 
induced transformation 
Unlimited 
hTERT-immortalized line Primary cells Unlimited 
 
Figure 1 Applications of animal cell cultures. From Eibl et al. 2009 [119] 
Table 1 Cell culture general classification 
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2 Alternative in vitro cell models 
2.1 Co-cultures  
Monocultures partially reflect the status of multicellular tissues, in particular when the scope of the 
investigator is to predict the susceptibility of the host during an infection, a process that is 
characterized in vivo by many cells interacting each other via direct contacts or paracrine signals. 
More meaningful in vitro models are co-cultures. Basically co-cultures are assembled when at least 
two cell types reproducing some cellular interactions (paracrine factors, juxtacrine signaling) are 
simultaneously cultured. Simple co-culture systems contain a mixture of cells in contact with each 
other (bi-culture), while patterned co-cultures need a physical separation between the cell types.  
The use of these systems is suitable to study specific cell-cell interaction (i.e. between a NK-Cell 
and a cancer cell) that can be timely controlled by separating in advance cell type locations. By 
introducing a compartmentalization, it is possible to study conditioned single cell type responses 
and recovery them in an easier fashion. This approach would allow a restricted evaluation of joining 
communication between different cells. According to the needs and the model simplification 
process, the diverse cell densities may be ideally approximated to the ones of the native tissue. The 
advantages of using such approaches are schematically showed in Figure 2. It is demonstrated that 
in vitro co-presence has enough influence to enforce regenerative potential of the system 
components [[1][2][3]. It permits to study rare events happening in nature or check synthetic cell-
cell interactions. It permits to study rare events happening in nature or check synthetic cell-cell 
interactions. It has been proven that co-cultures enhance phenotype markers (e.g., hepatocytes co-
cultured with endothelial cells or fibroblast exhibit normal hepatic markers and additional function 
than the classic albumin production in 2D culture), and allow to analyze activation of the 
inflammatory state (e.g. co-cultures of monocytes and epithelial cells). 
 
Of importance, the structure of the environment has to be defined and compatible at least with 
viable and stable cell populations. If co-cultures are intended for longer-term assays (“time-scale 
problem”), media requirements (including volume) are fundamental to the success of the 
experiment. In addition, data acquisition must be carefully pre-arranged, especially when co-
cultures represent valuable starting points to develop relevant pseudo-tissue models.   
2.2 Transwell systems  
Very smart devices that facilitate numerous co-cultures set-ups are cell culture inserts (by extension  
called Transwell). They are historically manufactured to perform migration and invasion assays, 
although they are frequently employed to mechanically support and compartmentalize the cell 
 INTRODUCTION 
  Alternative in vitro cell models 
  
culture. Many companies produce cell culture inserts with different material properties 
(transparency and toughness) and pore micro-sizing, allowing the user to choose the permeability of 
the barrier created by the insert according to the aim of the study (drug screening, microbial motility, 
etc). Technically they are placed in conventional cell culture plates, depending on insert format. For 
example, in the case of an epithelial cell culture, the use of transwells would allow the isolation of 
BL and AP layers leading to the possibility to distinguish their phenotypical differences. The 
characterization of the epithelium produced in trasnwells conditions it is not difficult. TEER 
measurement is just one method compatible to transwell cell culture systems; it is possible to use 
instruments such as EVOM or Endhom or Ussing chamber, to assess cell layer integrity and barrier 
function, considering the formation of cell junctions. Thanks to transwells and ALI-culture the 
achievement of considerable epidermal and mucosal equivalents is now moving to translational 
studies. ALI culturing success reflected our capacity to restore physiological parameters, such as 
free oxygen availability, recapitulating natural stimuli able to lead to the differentiation input within 
a tissue.  
2.3 2.5D cultures 
Just the simple addition of native ECM components in the medium is able to produce a tissue-
specific commitment and a structured organization by cells. This technique is referred as 2.5 cell 
culture. Different ECM proteins are recognized by cell surface interactors and as a consequence 
they assign an orientation that could influence the polarity. The seeding of cells on an organized 
layer of specific basement membrane proteins (such as MatriGel coating) is usually sufficient to 
promote sphere-like organization by cells. The choice of the ECM protein/s could also lead to an 
irregular distribution of the cells. Knowing those features conversely it is possible to exploit the 
spatial cells arrangement in a way to expose cell compartment in general not easily accessible; for 
instance, the addition in the medium of antibodies directed versus particular integrins allows the 
orientation of cell polarity during the culture initiation. These models are indeed a convenient 
“intermediate” between 2D cell culture and in vivo ones, more physiological in terms of parental 
architecture, leaving the cells open for downstream analysis.   
2.4 Fluidics contribution in cell culture  
Oxygen, nutrients and other molecules are continuously consumed and produced by cells. Such 
dynamic distributions are not mimicked in conventional 2D cell culture. Nevertheless, endothelial 
cells are continuously under shear stress conditions as blood flows over them. This aspect has led to 
the need of improving cell culture conditions by testing the effect of a precise force exerting on the 
physiology of cell cultures. These constrains have defined the rationale for applying microfluidics 
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technology to biological systems. Fluidic devices are tools to incorporate mechanical stress (e.g. 
pressure) or chemical challenge (e.g. increasing GF concentration) in cells that can recreate this 
dynamic environment in a small scale. Grouping of valves, channel, tanks and pumps consent to 
evaluate the response to forces and gradients that usually encounter in nature, like in the vasculature. 
Microfluidics provide high degree of control over cell culture conditions, especially if robotics is 
built-in, therefore enlarging mAbs or viral vectors therapeutics production yield in industrial 
workplace. Fluidic apparatus is suitable also for not-adhering cells. By filtration, gravitational 
settling and centrifugation, cells and medium containing the therapeutics molecules product of the 
culture, can be separated. Now, custom-friendly plates and microdevices are more and more offered 
in the market to the not-expert in the field to analyze particular cell populations (e.g. endothelial, 
myo-fibroblast) or for single live-cell analysis. However, this approach may encounter optimization 
problems such as a variable 1) flow rate (laminar or not); 2) consumption rate of nutrients; 3) gas 
levels (including evaporation problem) and 4) positioning of delicate cells in channels.  
Figure 2 Co-culture definition and motivation. From Goers et al. 2014[120] 
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Figure 3 Schematic of experimental output obtainable from a transwell-model of the respiratory epithelium 
Figure 4 Schematic representation of co-cultures set-up. In 2D culture a channel (a) or a membrane (b) or 
surface adhesion (c) separate single cells or colonies.  Evolution of these approach in 3D conditions 
comprised microfluidic hanging drop plates (d), bioreactors(e) and hydrogel encapsulation (f).  
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3 3D cell culture models 
A wide variety of engineered cultures to genuinely recreate the molecular circulation of signals in 
response to external perturbation have been developed so far[4][5], [6]. 
These models are meant to replace ex vivo ones that involve direct culturing of tissue from human 
or animal sources preserving their dimensions. Indeed, although ex vivo models are useful when 
animal tissue harvesting does not constitute a limitation, such approach is hardly feasibly for host-
pathogen interaction studies. Even though the technological advances in engineered model tissues 
are notably (e.g. in scaffolding or defined synthetic matrix), the mirroring of in vivo conditions 
remains a big challenge, mainly because of the highly heterogeneous and time-variable composition 
of the extracellular constituents. Indeed, each tissue has differences in their cyto-architecture and 
the actual determinants of cell differentiation are often not well-elucidated and the mechanical 
forces vary. The fundamental issue is the extent to which in vivo complexity of the tissue/organ is 
recapitulated in the designed 3D culture. One possibility is to deconstruct the organ/tissue into their 
smaller units (layers, cells or matrix) and then recombine them selectively in a 3D structure. 
Three-dimensional tissue engineered models can be mainly divided in scaffold-based and scaffold-
free constructs. Below are described a few of the most popular approaches. 
3.1 Scaffold-based constructs 
Implanting cells or tissues into a 3D scaffold composed of natural derived ECM or synthetic or 
semi-synthetic materials (such as hydrogels) is the most common technique that resembles the  
architecture of various tissue types. Such tissue equivalents are recognized as efficient toxicological 
study substrates, disease models and as general in vivo models surrogate. For instance, fibroblasts 
added to a collagen frame enable the formation of an underlying realistic dermis and the self-
organization of full human skin. Actually de-cellularized tissues, with the ability of retaining native 
composition and distribution of GFs and ECM, seems to be the most promising scaffolds suitable 
both to regenerative medicine and in vitro modelling tissue engineering, with a demonstrated 
success also in tracheal transplantation[7]. A lot of techniques are being utilized to fabricate solid 
scaffolds for 3D cell culture, including lithography, electro-spinning, bio-printing, microarrays. 
3.2 Scaffold-free constructs 
Spinner flask is the most used technique to generate suspension clustered cultures (spheroids), in a 
higher quantity than liquid overlay or hanging drop methods. Magnetic spinner prevents the cells to 
adhere to any surfaces and assists in nutrients and waste transport. However, this approach may 
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result in 3D aggregates, heterogeneous in size and shape and the physical forces applied can be 
detrimental on the behavior of cells. As an alternative surface to the traditional well and flask, 
micro-carrier beads are commercially available with a wide range of physio-chemical parameters, 
allowing the culture in rotating vessels. They appear advantageous wherever higher cell density is 
required, moreover for the culture of sensitive cells types (such us endothelial cells) and since their 
use decreases necrosis problems occurring in spheroids. 
 Organoid cultures were first described many decades ago, but just recently, caught the advance in 
stem cell isolation, their utility is increasing especially in translational study. Organoid cultures, in 
terms of cells explanted and self- rearranging, imitate the physiology of many human and animal 
tissues very well. Organoids protocols were available for the mammary gland, kidney, prostate, 
lung, intestine, stomach, liver, and pancreas [8] as well as tools for relevant prognostic and 
predictive assays. Organoids, expanded from ESCs, from iPSCs or from primary stem cells, are 
typically cultured into commercial matrices, enabling optical imaging. 
3.3 3D bioprinting 
3D bioprinting is being applied to regenerative medicine to address the need for tissues and organs 
suitable for transplantation. Compared with non-biological printing, 3D bioprinting involves 
additional complexities, such as the choice of materials, cell types, growth and differentiation 
factors, and technical challenges related to the sensitivities of living cells and the construction of 
tissues[9]. The integration of technologies from the fields of engineering, biomaterials science, 
physics, biology and medicine addresses the control of tissue geometry, mechanics and 3D 
patterning networks.  
3.4 Organ-on-a-chip 
An organ-on-a-chip is a microfluidic cell culture device. It is created with microchip manufacturing 
that monitor/control physicochemical cell environment and simulate tissue/organ physiology. By 
mimicking the multicellular and tissue-tissue interfaces and vascular perfusion of the body, these 
devices reproduce a superior functionality in vitro than conventional cell culture systems. 
3.5 Imaging in 3D cell culture 
Disappointingly, the imaging of 3D cultures is still challenging [4]. The main obstacle is the 
scattering of light in thick specimens. Confocal microscope enables multicolor imaging up to ~100 
μm deep within the tissue, while two-photon microscopy avoids this issue. Reduced photobleaching 
and phototoxicity, high resolution via multiple-view reconstructions, long working distance 
objectives and higher speed, make instead the LSFM ideal for 3D culture purposes. [6], [10]–[12] 
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Figure 6 Major aspects of different cell culture environments. Source: Shamir et al. 2014 [121]  
Figure 5 3D optical microscopy techniques in relation to 3D cell cultures methods. Source: Page et al. 2012[4] 
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4 Cellular systems for host-pathogen interaction 
4.1 Current infection models limitations   
Human organs incessantly changes microenvironments. The beginning of the infection causes 
firstly a homeostatic imbalance. Able to attach, internalize and survive inside the cells, bacteria arm 
their virulence machinery and adapt to this imbalance made of metabolic changes and immune 
response, thus starting a productive or recurrent infection. In this context, the in vitro studies are 
focused on the single cell types, comprised in the barrier function critical for the initiation of the 
disease. Epithelial monolayer cultures contributed to our understanding of how microbes use host 
receptor to establish their virulence, but remain unable to depict a global immune response to 
pathogens because of the absence of immune cells. Indeed the biological events triggered by the 
cytokines produced by discrete immune cell types can be missed when these cells are not present in 
the cell culture. In principle, by missing a single cell type we may alter the signaling events or 
factors favoring microbial colonization. 
Extensive use of monoculture in vitro is however often chosen because of the difficulties by in vivo 
models in recognizing host signaling pathways involved during pathogenesis. Even if the in vivo 
output is a general issue, in the field of infection diseases this is considered a non-trivial issue 
whereas the investigator has to consider the behavior of a specific human pathogen. The value of 
animal models in vaccine development is indeed part of a large debate in the scientific community. 
First of all, many bacteria are not widespread pathogenic among the mammalian species, in fact it is 
not rare that they exhibit a tropism restricted to particular specie to realize the infection. Our effort 
to recapitulate particular infection disease through an animal in vivo are most of the times imprecise 
for the choice of the model itself; they could be not predictive of the humans because of the 
difference in metabolism and anatomical infected districts. This topic is very important to be taken 
into account for intervention strategies and in particular for vaccine discovery, with the opportunity 
to decrease clinical trials failing. Furthermore, development of methods to replace, reduce and 
refine animal experiments (the 3Rs approach) is currently one of the major need of research and 
development of therapeutics.  
In contrast to the relative complexity of in vivo models, the comparison between monocultures and 
co-cultures are a controlled way to infer with the signals maintaining the cell-maturation and 
synergistic response to the microbes. Cell co-cultures are increasingly being used to study the 
pivotal role of discrete cells in response to microbial products or whole microbes infection. The 
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experimental design of course is affected by of both cell and microbe viability. Overgrowth of 
bacteria leads to hide small interesting events beyond a faster death of the cells. The use of UV-
radiated bacteria it is an optimal compromise to study microbial components because biochemical 
features of the whole-organism are preserved and have maintained function.  
In the last decade, serum-free condition is tending to be a must, almost for primary cells culture. In 
alternative, tissue microbiology and intravital techniques are emerging for that need, thanks to 
recent cutting-edge technology such as multi-photon imaging [13]–[15] 
4.2 3D cell cultures as new paradigm in infection biology studies 
Currently the most encouraging models able to acquire information about the host response to 
infections are 3D cell culture, especially for difficult-to-culture pathogens. They are valuable 
research tools when they are possibly coupled to a careful selection of the in vivo model. Usually 
the localization of TJs and ECM deposition in such 3D model like organoids can impact the process 
of the in vitro infection reconstituting a protecting barrier and preserving host cell integrity against 
invasion. As reported in the literature, 3D cellular models often generate data in agreement with in 
vivo reports and they have helped scientists to reconsider part of the knowledge derived from 2D 
cell cultures experiments. In particular, fortunate 3D cell cultures, even of cell lines, allowed the 
propagation in vitro of human specific viruses [16], not possible in the past neither in animal 
models. Intestinal organoids used to evaluate in vitro salmonella pathogenesis have shown that a 
mutant for invA gene (lacking a form of T3SS) is still able to invade the host [17]. This clearly 
shows that there could be bacterial components, previously considered essential in 2D culture, that 
are actually dispensable in a more physiological setting. 3D in vitro epithelial models also resemble 
the in vivo balance of pro- and anti- inflammatory cytokines following particular infections [14]. 
Likewise in 3D models, mucus is also patterned in a more physiological manner. Considering that 
the mucus can have a dual role with regard to pathogens, as innate barrier containing antimicrobials 
and material protection and as source of nutrients and pleasing ECM ligands, it is likely to influence 
a lot the output linked to the mechanism investigated. However, a major challenge for the study of 
host–pathogen mechanisms in three-dimensions is the use of biomaterials that will not affect 
verisimilar cell exposure to pathogens and exclude a non-physiologically manner interaction [18]. 
4.3  Opportunistic pathogens emerging  
Although we have a good comprehension of the epidemiology and of clinical manifestations of 
several infectious diseases, sometimes we miss the relevant information to understand how the host 
colonization process influences the onset of disease. Bacteria living in normal human flora live as 
commensals until the equilibrium among the bacterial resident species are not disturbed. Our 
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attempt to treat and prevent particular diseases led in a simultaneous increase in pathogenicity 
acquirement by commensals bacteria. This switch to the opportunistic behavior is evident for two 
bacteria taken in exam in our study, NTHi and C.difficile, and here below briefly described. 
4.3.1 Non-typeable Haemophilus influenzae  
H. influenzae is a gram-negative coccobacillus. Isolates of Haemophilus influenzae are divided into 
encapsulated and nonencapsulated forms, with the last lack serotypical discrimination. Non-typable 
Haemophilus influenzae (NTHi) is a human-restricted member of the normal airway microbiota in 
healthy carriers and an opportunistic pathogen in immunocompromised individuals. NTHi is 
recognized a significant pathogen in children, and also in adults is the main cause of otitis media, 
community-acquired pneumonia, COPD, exacerbations in cystic fibrosis. Importantly, invasive 
diseases caused by NTHi infections have been steadily recognized since Hib and pneumococcal 
vaccination began. [19] 
Nonencapulated strains present a huge heterogeneity linked to virulence factors differential pattern, 
thus varying the interplay with the host and making stronger therapies useless. In NTHi we referred 
for LOS (and not LPS) because a lipid A moiety and saccharide core but no O side chains are 
present on the bacterial membrane. LOS and ProteinD are considered major ciliotoxicity effectors. 
OMPs are implicated in mucus adherence and antigenic variation. More virulent NTHi strains can 
count in a panel of adhesins: HWM, Hap, Hia (similar to Hsf of Hib). Host immune mechanisms are 
needed to be evaded and to reach a persistent state at the mucosal airway surfaces. This is the 
reason why NTHi expresses an IgA1 protease that specifically contributes to counteract local 
immune response. The phase variation, i.e. the capacity by NTHi of challenge its surface structures 
to quickly adapt under different host conditions, is mostly associated to LOS modifications, in 
particular with sialic acid and ChoP decoration [20].  
NTHi strains are adherent in vivo and to AP of transwell polarized airways cells (like CALU-3) and 
were confirmed to form biofilm which increases antibiotics resistance. NTHi seems can cross the 
epithelial barrier, assumed via paracytosis, and survive inside epithelial cells, then trespasses the 
subepithelial space with the option to infect also non-epithelial cells Figure 7. Whether NTHI 
resides in the respiratory tract is a question with no clear answer so far. Several bronchial models 
were used in the past, comprising ALI-transwell based (Baddal et al, unpublished) and 
Epiairway[21], to characterize the effect of long-term co-culture of NTHi with human tissues, but a 
deeper understanding of microbial virulence factors and live infection studies are required to 
decipher the best strategy to develop vaccine against NTHi broad spectrum.  
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4.3.2 Clostridium difficile 
C. difficile is gram-positive bacillus, obligate anaerobic and spore-forming bacterium.  CDI is at the 
present considered to be one of the most important causes of health care-associated infections, with 
a recent increase in mortality trend. The cause is traceable in the wrong or over-use of antibiotics 
provoking the intestinal microflora unbalance. C. difficile transmission follows fecal–oral route. The 
incidence of infection is greater in hospitals due to C.difficile acquisition through ingestion of 
spores, the same transmitted from healthcare personnel and other patients as well. An overview of 
the pathophysiology events is resumed in Figure 8. The formation of a pseudomembrane is a 
characteristic sign of inflammatory C. difficile reaction.  Clinical manifestations in adults can range 
from mild diarrhea to even death (fulminant colitis, toxic megacolon, peritonitis). The most 
characterized as well important virulence factors are Toxin A (TcdA) and toxin B (TcdB), which 
are located, along with surrounding regulatory genes; without this equipment such C.difficile strain 
is considered non-pathogenic. Usually an IgG response to ToxA makes the difference between a 
non-asymptomatically carriage and onset of CDI. The diagnosis is traditionally based on the 
cytotoxin neutralization assay with high sensibility (but usually detecting only the more potent 
ToxB) and progressed into high specific immunoassays against both toxins. Antimicrobials 
administration (vancomycin and metronidazole) unfortunately disrupts the protective microflora, 
guiding to recurrent CDI symptoms nonetheless. Currently the best therapy appears the fecal 
transplantion, MAbs development (against the toxins) showed great potential to cure but has to be 
improved, while a vaccine is still far to be released.  [22], [23] 
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Figure 7 Model of NTHi infection. Source: Clementi et. al 2011[122]   
Figure 8 Pathogenesis of C. difficile infection. Sources: a) Poutanen et al 2004, [123] b) Rupnik et.al 2009 
[22] 
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AIM OF THE STUDY 
5 Thesis objectives 
Standard in vitro models are not able to totally capture the physiological complexity typical of body 
districts, such us the lung or the intestine, and this limits the capacity to develop vaccine based on 
the understanding of bacterial infection strategies. Recently developed 3D cell culture models can 
better represent  the tissue physiology and can work as valid human in vitro tissues equivalents. 
In this context my PhD project has been focused on the development and evaluation of primary cell 
3D models, with the objective of providing a new tool suitable for antigen discovery with the 
specific aim of unravelling mechanisms typical of pathogenesis dynamics, microbial cell targets and 
immune evasion. To achieve these goals we planned to reconstruct in vitro distinct host niches 
representing in particular the mucosa that acts as first innate defense against bacterial 
colonization.and infection. 
The main objective of my study has been to set up reproducible conditions allowing the formation 
of a human organotypic culture of the conductive zone of the human respiratory tract. In particular 
the strategy was to setup a mechanical supported co-culture, centered on a two-component cell 
system reflecting the key features of the epithelial and connective tissue. We also created models 
based on three cellular components. These systems were planned as alternatives for current cell-
lines based studies of binding, uptake, transcytosis, co-localization, toxicity, cellular activation as 
well as immune cell recruitment. The main characteristics of the 3D model are:  
 consistency for a long-term study; 
 adequate biomimicry; 
 comfortable access to the epithelial face to perform apical infection; 
 unnecessary automation, basic equipment sufficient;  
 prospect of cellular tracing; 
 protein localization; 
 proven heterotypic cell interactions; 
Our strategy has been based on the chronologic and modular introduction of the following elements: 
 a synthetic scaffold, to support the cellular micro-scale environment; 
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 HLFs, as main constituent of the mesenchyme; 
 HBECs, as source of epithelial cells; 
 ALI-culture to stimulate differentiation trough air exposure; 
and alternatively: 
 innate immune cells or stromal stem cells, as a third cellular component; 
 176 NTHi strain, to perform a suitable infection;  
 PBMCs, to study their recruitment to the infection site. 
We deeply characterized the 3D model especially by the use of  microscopy. 
Furthermore, as secondary objective, we planned to use a promising protocol to grow a gut-derived 
cell model, whit a major focus on the identification of cell components targeted by toxins and on 
epithelial homeostasis disruption by microbial virulence factors. Indeed we investigated mouse-
derived EnOs in terms of growth, selective vulnerability and survival, after exposure of C. difficile 
TcdA. 
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DEVELOPMENT OF AN ORGANOTYPIC 
RESPIRATORY MODEL  
The human respiratory tract has the crucial role of exchanging gases with the external environment 
and it is usually sterile in the section that goes from the glottis to the lungs. Somethimes happens 
that commensal or pathogenic bacteria can exceed the natural barriers and colonize/infect the 
middle-lower airways. Indeed during the basic function of breathing, airways are exposed to 
external particles comprising bacteria and viruses. Therefore the air filtering process is a vital 
function of the respiratory tract in which the innate immune system is involved.   
6 Literature review 
6.1 Human airways anatomy, cell types and function 
The human respiratory tract differs in mammalian species for length and histology of the different 
tract (see Figure 9), as consequence of different metabolism and oxygen uptake. We will focus on 
the conducting zone (CZ) comprising nose, pharynx, larynx, trachea, bronchi, divided in 2 main 
compartments, mucosa and submucosa; taken together, the macro structure is formed by 
consecutive layers, starting from the epithelial one, then the connective tissue, smooth muscle tissue, 
cartilage in superior part. Proceeding to lower anatomical regions the cartilage and glandular tissue 
are reduced, while muscles presence depends on the physiological difference in the tract. The 
significance of the variation in distribution of secreting cells and mucous glands in the different 
species is uncharacterized. Alternatively, the division of the respiratory system could refer to upper 
and lower respiratory tract, with larynx working as dividing line.   
The respiratory mucosa shares 2 zones, which are the epithelium and the lamina propria. Lamina 
propria is formed of connective tissue with inclusion of capillaries, mucous glands and resident 
immune cells. However, until the end of conducting zone and before the respiratory zone 
performing gas exchange (respiratory bronchioles, alveolar ducts, and alveoli), the epithelium is 
pseudostratified and columnar, covered by mucus and motile cilia. Basically, the pseudo-layer 
consisted of three main types of cells: ciliated epithelial cells, mucus cells and basal cells.[24] 
Basement membrane (BMe) is the ECM separating wall between the two parts of the mucosa; it 
anchors epithelial cells making strong their adhesion, it provides survival signals for the epithelium, 
it attends to cellular polarization, it works as a physical barrier. The upper layer of the basement 
membrane is the basal lamina, divided in lamina lucida and lamina densa (mostly collagen IV and 
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laminin V) secreted by epithelial cells, while the lower is lamina reticularis synthesized by 
subepithelial cells. [25][26] 
 
6.2 Major cell types and components of the conductive airways 
Ciliated and mucus cells work together to conduct the so called mucociliary cleareance, in which 
pathogens are trapped in mucus and then removed by cilia.  
Ciliated cells (CCs) represent over 50% of external epithelial layer and are responsible for the 
mucus transport, ans as consequence for the clearance of external material trapped in. Hundreds of 
cilia are outstretched from the AP of each ciliated cells, with basal bodies working to anchor them. 
A lot of mitochondria are necessary to transmit energy to the cilia coordinated beating. Average 
lenght of cilia is ~6 μm [27]. CCs are defined high-grade differentiated, their maturation is 
dependent on FoxJ1 expression. The mucous layer acts as a fluid reservoir and maintains constantly 
humid cilia lengthways.  Two major mucins are present in human airways: MUC5AC and MUC5B, 
produced respectively by Goblet cells (GCs) and submucosal glands. Mucin production was shown 
to be regulated by inflammatory mediators [25], such as LPS, TNF-a and IL-1, IL-17, IL-13. 
Mucus-producing goblet cells are sparse in the airways of adult mice but abundant in human 
airways [28]. GCs, by electron microscopy, have a cytoplasm containing electron-lucent granules, 
rich in high molecular weight glycoproteins, which are acidic [29]. Different oligosaccharide side 
chains  (with sialic acid or sulfate) can be detected by histochemical techniques, such us AB for 
acidic mucins and PAS for neutral mucosubstances. 
BCs are the most characterized part of the endogenous progenitor cells present in airways[30]. They 
lie on basement membrane in trachea and main bronchi. New markers for the identification of basal 
cells based on in vivo studies are continuously discussed, however many of them are established for 
the respiratory epithelium (Figure 13).Among this list it is recognized the prominence of p63, a 
transcription factor expressed at basal cells of stratified epithelia throughout the body. Mice 
homozygous for a mutant Trp63 die postnatally [31]. In normal lung, p63 intensely stained nuclei of 
bronchial reserve cells but did not stain ciliated cells or alveolar epithelial cells, neither non-
epithelial cells. p63 is expressed in BCs lining the BMe in bronchial epithelium. AQP-3, protein 
channel present in epithelia exposed to water loss [32]. Relying on transplantation studies of fetal 
human respiratory tissues into immunodeficient mice, AQP-3 was shown to mark basal layer of 
cells and able to regenerate mucociliary phenotype and glandular also [33]. In general, at molecular 
level Notch signaling is required for the differentiation, but not self-renewal, of BCs. Sustained 
Notch signaling activation, which promote secretory than the ciliated fate, is required for luminal 
differentiation [28], [34]–[36].  
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6.3 Minor cell types 
Furthermore there are other cells such as brush cells and endocrine cells (PNEC). Brush cells 
possess a tuft of microvilli at their apical surface and apart from a possible absorption role, their 
function is still to be characterized, but recent evidences suggested they are chemosensory cells. 
They also seem to recognize microbial compounds and modulate epithelial response to the infection. 
PNECs (or Kulchitsky Cells) also occurs individually, with pyramidal morphology, or in small 
cluster called NEB, they are known to produce many kind of granules, including serotonin and 
calcitonin, they sense hypoxia and nicotine, are innervated by sensory nerve fibers.  
6.4 Host-defense and immunoregulatory cell types 
Following airway damage, immune system and proliferation and differentiation of resident 
progenitor or stem cell pools are necessary in order to maintain a protective barrier.  
Moving towards the respiratory zone, the epithelium becomes a simpler columnar/cuboidal 
monolayer and all the three cell types, described above, gradually reduce in number, in favor of 
Club cells appearance. Club cells (ClC) are non-ciliated secretory cells, present mainly in 
bronchioles and with a very heterogeneous morphology among the species.  They reverse into the 
lumen secreted forms of CSSP (also known as uteroglobin, CC-10), mucins, specific antiproteases, 
p-450 mono oxygenates and antimicrobial peptides. Surprisingly they also act as progenitor cells 
where BC population is decreasing according to the anatomical changes. Indeed their function 
Figure 9 Anatomical and histological structure of human airway wall. Adapted from Berubè et 2010 [124], 
Roomans et al 2010 [125], Wansleeben et al 2013 [36] 
 DEVELOPMENT OF AN ORGANOTYPIC RESPIRATORY MODEL 
  Literature review 
  
translated from pulmonary host defense hypothesis to a stem cell reservoir population. They have a 
repairing role, protective against direct external damage than the normal cellular homeostatic 
replacement. Club cells are ready to exit from a steady state for replicating and substituting high 
differentiated cells as Ciliated or Goblet (that’s possible to talk about “redifferentiation”). In 
addition, Club cells are able to dedifferentiate in BCs [37] in case of their ablation or either in AECs 
after lung chemical injury [38]. The pathways controlling differentiation and development of Club 
cells are poorly characterized and they are conditioned by ongoing in vivo lineage-tracing studies.   
In addition, immune cells residing within the mucosa are freely to migrate between the two 
compartments, because the presence of specialized pores in BMe [26]. These cells include mast 
cells, intraepithelial lymphocytes, dendritic cells and macrophages; in some cases there are 
organized lymphoid aggregates called BALT [39]. Many groups searched for the number and 
localization of the immune cells resident in the airways, but imprecise description was recorded, 
perhaps resulted by limitations techniques at that time. It is not the intention of the thesis to discuss 
about all this immune cell types, except a note for dendritic cells. They are powerful APC, involved 
in the second innate mechanism of defense (see Figure 10) 
Residing within the airway mucosa, pulmonary DCs (p-DC) sample the content they caught, 
migrate and then present these antigens to T-cells. In the lung the migratory patterns of p-DCs are 
highly dependent upon inflammatory conditions. DCs recruitment to the lung is increased and 
renewing after injury challenge and inflammation onset. Resident p-DCs are not a homogeneous 
population, maybe because they reflect different stages of maturation, and for this reason their 
classification is generally based on anatomical location or surface markers. In 1986 APCs with 
dendrites were found within the human airway wall, just above the basal lamina, with extending 
cytoplasmic processes [40]. Their identification in human bronchial tract was confirmed after 
different tissue digestion protocols and lung sections immunohistochemistry against MHCII (high 
levels) [41] but also by infrequently positive staining for CD1a [42]. Studies regarding their 
localization (dissimilar among the species) studies in CZ and phenotypic analyses showed that the 
human intraepithelial DCs have more endocytic activity (supposing a tolerogenic one), CD1a 
expression (similar to Langherans cells [41] whereas the subepithelial cells do not [43]. According 
to this investigation [44] the p-DCs seemed to possess an immature phenotype similar to the in vitro 
DC obtainable with the protocol provided by Sallusto [45].  
Last noticeable cell type that should be introduced are Mesenchymal stem cells (MSCs). MSCs 
represent a heterogeneous subset of multipotent stromal cells, resident in many different adult 
tissues, that exhibit the potential to give rise to cells of diverse lineages, not only mesodermal. 
MSCs are widely defined and accepted by ISCT as population with positive simultaneously 
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expression for CD90, CD105 and CD73, with a concomitant absence of CD45 and CD34 [46][47]. 
MSCs have potent paracrine trophic, anti-apoptic, angiogenic, but especially immunomodulatory 
effects. In particular they are poorly immunogenic, immunoprivileged and immunosuppressive [48]. 
Unlike MSCs isolated from many other tissues, lung resident MSCs (Lu-MSC) still lack of 
conspicuous characterization and their recognition is recent among the scientific community [49]. 
Lu-MSCs were isolated probably for the first time by Sabatini [50] in bronchoalveolar lavage fluid 
from human lung allografts [51] as well as fetal and adult lung digests [52] and tracheal aspirates 
[53]. 
The beneficial effects of MSCs after injury are likely linked to indirect support to the epithelium 
instead of a direct replacement / substitution role of the damaged cells. The idea is that Lu-MSCs, 
as BM-MSCs, create a supporting environment for HSCs during haematopoiesis. HSCs are an 
essential element of the epithelial stem/progenitor cell niche in the adult lung. Despite it is still 
controversial whether Lu-MSCs can undergo mesenchymal-to-epithelial-transition, [54]. A  
comparison study not only confirmed that Lu-MSCs possess part of the immune regulatory 
properties broadly described in BM-MSCs, but also showed a partial in vitro differentiation toward 
the epithelial lineage.  Recent in vivo studies indicate that mesenchymal stem cells (MSCs) can 
boost the treatment of sepsis induced by bacterial infection in lung and gut animal models [55], [56]. 
It seems that apart from capacity to interact and recruit immune cells activity [57], [58] also their 
intrinsic antimicrobial properties [48] are capable to improve survival and enhanced bacterial 
clearance. They indeed produced antimicrobial peptides such as LL-37 [59].  Unexpectedly the 
antibacterial role of MSCs is not proven by a consistent medline. In vitro MSCs (compared to HLFs) 
inhibit the growth of Gram– and Gram+ bacteria, and even their conditioned medium [60]. Recently 
in vivo administration of MSCs and of their microvesicles showed reduce acute inflammatory lung 
injury [61] . This data are maybe the last accompanying the evidence of MSCs beneficial activity in 
endotoxemia, acute lung injury, or sepsi models. For further information we suggested our 
references list [62]. 
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Figure 11 Schematic of basement membrane at the axis between epithelium and lamina propria. Source: 
Tam et al.2011. 
Figure 12 Immunohistochemical analysys for CD1a (A) and Langerin (B) in human lung sections.  Source: 
Brandtzaeg,et al 1995  
Figure 10 The three immune functions present at the level of the mucosa. Source: Demedts et al.2005. 
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Figure 15 Criteria for the definition of MSCs. Source: Le Blanc.et al 2011 
Figure 14 Model for the self-renewal and differentiation of basal stem cells in mouse and human airways 
Source: Rock et al 2010.  
Figure 13 Selected markers list for BCs. Source: Rock et al. 2010 
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6.5 State of art: cell culture models of the airway 
The progress in cellular biology methods and ex-vivo models currently allow scientists to examine 
minute mechanisms such as happening during early embryonic lung, but this possibility, as we 
already mentioned, is restricted and not feasible to study several host-pathogen interactions because 
immediately restricted to availability of organs from laboratory animals. 
Until last decade the models used to understand microbial interaction with the host, also to study 
epithelial airway cells, were commonly human cell lines, like alveolar cell line “A549”. The latter 
are continuously used in non-appropriate mode in host-pathogen interaction protocols without 
curing the fact that is functionally deficient for TJs formation and epithelial integrity.  The bronchial 
epithelium 16HBE14o- or BEAS-2B, cell line are not able alone to display a physiologically close- 
reconstruction of that tissue, such as a simultaneous cilia formation, mucus secretion, TJs 
expression, epithelium repair capacity. Indeed BEAS-2 cells resulted instead unsuitable to study 
airway barrier function, lacking marker of full differentiation capacity (mucins) and showing poor 
TEER. As confirmation of aberrant cell phenotype and discrepancy among laboratories protocols, 
the formation of functional 16HBE14o– cell layers requires the presence of submerging condition, 
in contrast to other airway epithelial cells [63].  
The actual more recognized model to study absorption and permeability of airway epithelia is Calu-
3, lung adenocarcinoma cell line. Cultured at ALI those cells acquire a great secretory phenotype, a 
columnar morphology and showed a similar TEER trend in comparison with primary bronchial 
cells. Unfortunately, unlike primary bronchial cells, Calu-3 polarized on transwells, even after ALI 
phase, do not differentiate into layers of basal cells or mature cells developing cilia, probably 
because their parental epigenetic memory is linked to a phenotype similar to gland cells. in this way, 
ALI conditions for Calu-3 cells are not as critical in promoting cellular differentiation as it is for 
HBECs. Pronounced polarization occurs either in submerged conditions [64] while mucin secretion, 
and tight junctions can vary a lot between ALI / submerged conditions. Generally, all the above cell 
line system still require serum–condition, retain of a spontaneous uncontrolled tumor-derived 
growth capacity or own a differentiation potential stopped by in vitro transformation. 
Recently, scientists strive to get outcome from primary cells or combinations of cell lines in co-
culture. HBECs obtained directly from biopsies are available as low passage from several 
commercial sources. HBECs constitute a multipotent population of cells (p63
high+
) [37], [65] that 
share markers with the airway basal cell signature. This purified population is capable of self-
renewal. Higher cell passage (>4
th
) lose the ability to differentiate in a complete mucociliary 
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phenotype [66], in contrast to hTERT immortalized BC line (like BCi-NS1)[67] that retains 
characteristics of the original primary cells for over 40 passages.  
Previous history on bronchial primary cells documented the importance of some soluble factors in 
this kind of culture. Serum-free condition is more functional to obtain multilayers and 
differentiation of epithelium [68], [69]EGF stimulates the proliferation and influences the cell 
maturation process. BPE is mitotic agent and it is involved in ciliated differentiation [70].  RA is 
extremely important precondition to reach tissue differentiation [66].  
By the way, ALI phase is preferable in culture primary cells, because is more physiological 
condition to recapitulate airway epithelium function than submerged conditions [71]; the switch to 
evolve AP in a “dry” culture certainly affect the thickness (cell height and number of cell layers) of 
the epithelium in a time-dependent manner [68], [72]. Extensive time in culture in some cases cause 
the de-differentiation of the forming in vitro tissue. 
The possibility to resemble the whole respiratory epithelium in 2.5D culture models arose just few 
years ago [73].Rock et al., starting from fractionated CK5
+
 murine basal cells, showed the 
formation of “tracheospheres” within 1 week, immersed in Matrigel plated on transwell membranes 
and grown under ALI conditions. By day 20
th
 these surviving spheres underwent luminal expansion 
and contain differentiated CCs and BCs. The same result was obtainable starting from human 
airway NGFR
+
 ITGα6+ cells. No secretory cells were detectable in that system. A similar approach 
was made by Wong and co-workers and their study confirmed the multipotency of (commercially 
available) HBECs under different culture protocols [74].They obtained glandular acinar structures 
when HBECs were overlaid on Matrigel and covered with an EGF-enriched medium (protocol 
similar for mammary acini morphogenesis [75]). Efforts recently published by Danahay et al. 
reported “bronchosperes”, derived from HBECs, that recapitulate the key elements of the 
conducting pseudostratified epithelium [76] and that enable HTS discarding transwell use. Thanks 
to a similar report, we know that progenitor cells of the respiratory zone, identified in AEC2s [77], 
can form self-renewing and differentiated (both mature AEC2s and AEC1s) “alveolospheres” [78] 
when they are co-cultured combining transwell, matrigel and ALI conditions, with  primary 
PDGFRα+ lung stromal cells (a population that include fibroblasts and lipofibroblast in proximity of 
alveoli[34]. In parallel, importantly, MRC5s (human fibroblast cell line) were necessary to support 
isolated HTII-280+ cells (AEC2s cells) to form human alveolospheres however without retaining the 
differentiating capacity[77]. Alveolar spheroids obtainable stimulating iPSCs are described in a co-
culture with fetal lung fibroblasts [79].  
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Use of transwells and of natural ECM substitutes enabled more complex co-culture setup.  
A sophisticated 3D airway in vitro construct has been established with the aim to offer a model to 
study angiogenesis in asthma, but the work made known the importance of the use of cells co-
cultured in 3D conditions to develop an organized capillaries network. HUVECs were coated on 
dextran beads and suspended in a fibrin gel toghether with a sheet of HLFs and finally HBECs, 
separately differentiated on transwell inserts, are added to the co-culture. The addition of HLFs in 
gels to the model was critical to allow HUVECs migrating off the beads, while HBECs promoted an 
increase in VEGF production thus suggesting a role in directing angiogenesis. Further evidence of 
the importance of the heterotypic interactions happening in lung and interesting to develop 
intelligent in vitro set-up belonged to a model of airway branching [80]; 3D-culture of VA10 (a BC-
like cell line) in presence of HUVEC generated bronchio-alveolar structures that are regulated by 
stromal soluble factors as FGF. Interestingly, VA10 alone or HUVEC monoculture (in the same 
Matrigel conditions), or neither A549-HUVEC co-culture, displayed branching, pointing out the 
importance to respect the tissue origin to arrange as much as possible the proper artificial niche.  
The choice of the epithelial cell type should be very careful: co-culture of HBEC/Wi-38 but not of 
16HBE14o-/Wi-38 made a both multilayered and differentiated epithelium [72]. Goto et al. had the 
distinctive idea to use natural biological membrane rich in ECM, like amniotic membrane, as 
replacement of the BMe to differentiate HBEC and afterwards add tracheal fibroblasts for the last 
part of the culture [81].  
We preannounce that a lot of the existing models are based on collagen matrix populated by stromal 
cells to mirror the lamina propria. Like what happens in dermal equivalent reconstruction [82], 
many 3D airway model were generated until now by embedding lung fibroblast in a collagen matrix 
[83]. A very elegant protocol was offered by the group of Swartz to develop a physiological 3D 
model with primary human epithelial cells and fibroblast embedded in a gel [84]. Such sort of 
models, like the one achieved by Vaughan et al., cannot exclude the contraction phenomenon by the 
gel [85].“Bronchial equivalents” proposed by Paquette et al. revealed that optimal peripheral 
anchorage of the gel prevented collagen contraction by fibroblasts, showing a way to fix this 
technical complication [69]. Interestingly, Pageau et al. showed how collagen concentration and 
composition affected the phenotype of bronchial epithelial cells in 3D culture, as well the 
contribution of tumoral fibroblasts (as soluble factors carrier) can interfere with the epithelial 
homeostasis[[86]. Indeed different subtypes of fibroblasts can exert different effects on the 
epithelial cells and viceversa [87]. 
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Relatively simply transwell co-cultures of epithelial cell lines and immune cells demonstrated that 
there are tissue responses such us particular cytokine production only in presence of inter-cellular 
communications and paracrine signaling [88]. Previously Chakir et. al compared the interaction 
between immune cells (T cells) and derived bronchial resident cells (HBECs and HLFs) between 
normal and asthmatic biopsies [89]. Among the concrete attempts of coupling innate immune cells 
with a respiratory mucosa equivalent, the list goes to be shorter. Since ten years ago Rothen-
rutishauser and colleagues worked to develop immunocompetent lung co-cultures; A549 cells, in 
the form of transwell monolayer, were surrounded on their polar sides respectively by macrophages 
and dendritic cells, with the aim to analyze particles interactions in a relevant model [90]. Choe et 
coworkers adapted their model, mentioned before, to unravel thin mechanisms during airway 
remodeling; by introducing eosinophils in the epithelial-mesenchymal culture they discovered that 
the combination of mechanical strain and activation of inflammation (but not by either one alone) 
induced epithelium thickness [91]. 16HBE14o– epithelial cells and human blood monocyte-derived 
macrophages and DCs are organized in co-cultures by Lehmann et. al. in 2010 [92]. Later, 
Svensson group developed a beautiful transwell supported model containing 16HBE14, DCs and 
MRC-5s. In the last case, the use of cell lines was justified by the advantage of easily tracing 
transfected fluorescent cells [93]. The dendritic population was confirmed to be a mobile element in 
the artificial environment set. The same group was able to show that the DCs are responsive 
external stimulation, like inflammation stimuli given to the organotypic model, finally following 
DCs fascinating migration within the model. Similar reconstruction was described and published in 
2014 [94]. A 3D model comprised of these 3 key cell types present in upper airway epithelium 
(Calu-3, MRC-5 and DCs) were initially grown on individual scaffolds and then assembled together 
before probing the model with inflammation mediators [95].  
Original investigation was carried on by whom wanted to check the benefits to include interesting 
stromal population like MSCs in airway in vitro systems. Transwell inserts were used as BMe 
substitute on which adult BM-MSCs were cultured on the lower side and NHBEs on the opposite 
one [87] . Analysis of apical secretions showed that mucin production increased over time, with 
peak secretion for NHBEs alone, whereas the secretion by NHBE cells co-cultured with MSCs 
remained constant for an earlier and longer period. In particular Kobayashi et. al evaluated 
differential contribution of gingival fibroblasts and A-MSCs to the differentiation of a 3D collagen 
model suitable to be transplanted [96]. Fibroblast density was correlated with GCs production and 
comparable to alternatively used tracheal fibroblasts. A-MSCs seemed to give an advantage in 
epithelial cell proliferation (at the level of BC) but in the absence of fibroblasts, there was no clear 
cell polarity [96] 
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Definitely, above described panel of references enhances the role by environmental conditions and 
of cell type itself to affect the differentiation of cells in 3D culture. Moreover this fact suggested 
and impacted the development of airway mimicking in vitro models too.  
 
Figure 18 Overview of epithelial model of the bronchial tract. Source BèruBè et al 2010 [124] 
Figure 17 Unsupervised clustering of epithelial 
respiratory cells. Source: Pezzulo et al 2011[71] 
Figure 16 Roles for p63 in the development 
of a stratified epithelium.Adapted from: 
Blanpain et al 2007 [127] 
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7 Methods 
7.1 Lung-derived cell cultures and characterization 
Normal human lung fibroblast (NHLF) were purchased from Clonetics™ and cultured in in FGM-2 
(Lonza). 3
rd
 P single stocks are expanded in Falcon T75 flasks. For the 3D model co-culture NHLF 
until passage 8
th
.  
HBEC are obtained from Clonetics™, specifically normal human tracheobronchial epithelial cells 
(NHBE) are cultured in BEGM (Lonza) and cryopreserved at 2
nd
 P.  Medium selection for ALI 
phase was decided comparing B-ALI(Lonza), that we indicated as m1, and PneumaCult™-ALI 
(STEMCELL Technologies
TM
), abbreviated as m2.  
For the 3D model co-culture NHBEs are expanded in BEGM in Falcon T75 flasks. NHBEs at 3
rd
 P 
are prepared for the differentiation protocol when the confluence is about 80%. PneumaCult-ALI is 
the medium used to switch 3D NHBE-culture to the ALI phase. Falcon 12 well-plate Transwells 
with 0.4 μm, coated with collagen type I solution 0.03 mg/mL for at least 2 h at 37°C, are used to 
support monolayer differentiation of NHBEs, to check the capability of a HBEC-monoculture to 
differentiate successfully in parallel to the 3D culture containing them. Cilia beating was assessed 
by optical microscopy and registered by AxioCam with maximum framing rate and 10X or 20X 
optical zoom [Zeiss][data not shown].  
Accutase solution (Invitrogen) is chosen as dissociation agent for the passaging of lung cells. Usual 
incubation required to detach cells is 5 min for NHBEs  and 3 min for NHLFs. 
7.2 Generation of Dendritic Cells 
Buffy coats drawn with informed consent from healthy donors are used as source of human PBMCs 
that are isolated by Ficoll-Paque™ density gradient centrifugation. PBMCs are then processed using 
Pan Monocyte Isolation Kit MACS® Technology (Miltenyi Biotec
TM
) or RosetteSep™ Human 
Monocyte Enrichment Cocktail (STEMCELLTechnologies
TM
) to obtain CD14
+
 CD16
+
 monocytes 
by negative selection. Monocytes are seeded in Falcon 12-well plates at density of 500000/mL in 
advanced RPMI 1640 Medium (Gibco®) supplemented with 10% Fetal Bovine Serum, beta-
mercaptoethanol 50 μM, GlutaMAX™ 2mM, and PS solution. To promote in vitro differentiation 
of immature Monocyte-derived Dendritic Cells (MoDC) purified monocytes are cultured for 6 days 
in presence of 50 ng/mL of human recombinant GM-CSF and IL-4 (Gibco®). Cytokines 
supplemented medium is refreshed once after 3 days, saving all non-adherent or loosely adherent 
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cells by centrifuging. On 7
th
 day single MoDC aliquot i harvested, the cells are stained with 
antibodies cocktails for CD209, CD14 and CD83 (Miltenyi) and surface expression was analyzed 
by flow cytometry to evaluate their differentiation stage. Different blood donor preparations were 
preliminary analyzed to check maturation state and donor variability of fresh or thawed 
cryopreserved MoDCs. Phenotype is compared to a preparation obtained from the same donor using 
a commercial ready-to-use G4 MoDCs generation kit (Humankine).  
7.3 Mesenchymal Stromal Cell culture 
Umbilical Cord - derived Mesenchymal Stem Cells (UC-MSCs) screened for specific stem cell 
surface antigens and derived from human Wharton’s Jelly were purchased from ATCC®. They are 
propagated in MesenPRO RS™ (Gibco®) plus Primocin antimicrobials (Invivogen). Retention of 
multipotency after expansion period is evaluated checking mesenchymal differentiation towards 
adipogenic lineage. In vitro adipogenesis induction is performed trough adipogenesis differentiation 
kit (StemPro®), following the technical sheet indications, culturing MSCs for 2-3 weeks in cell 
culture plate or even in alvetex scaffold. IL-10 release by MSCs is tested by intracellular 
immunofluorescent staining and measured by flow cytometry [data not shown]. For 3D cultures 
MSC are used until passage 7
th
.  
7.4 PBMCs labeling 
CFSE 10 μM in PBS is the labelling solution for PBMC, the reaction works at RT. After 2 washes 
in PBS pelleted cells are resuspended in medium. Correct uptake of the dye is checked under 
fluorescent microscope. PBMCs aliquot is checked for viability by trypan blue exclusion.  
7.5 Stromal 2D-co-cultures 
UC-MSCs and NHLFs are seeded sub-confluent and cultured in 6-well plate as monoculture or 
mixed each other in 1:2 ratio, to select optimal medium conditions for co-culture. Analogous co-
cultures, excluding hybrid cell-cell interactions, are set to distinguish the growth of the two inquired 
cell types; MSCs are cultured in the upper chamber of transparent Transwells 0,4 um pores while 
NHLFs in the lower chamber. Alternatively Flowell plates (Corning) are prepared separating MSCs 
and NHLFs populations, seeded with identical density, respectively in 1
st
 and 3
rd
 column of wells 
and using the middle column well as medium reservoir.  FGM2 and MesenPro media combinations 
are tested. After 1 week culture the cells are fixed and stained with methyl violet 0,5%. mitotic 
figures and cell number is estimated.  
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7.6 3D cell culture set-up 
7.6.1 Mesenchymal layer production 
Alvetex® Scaffold 12-well inserts are pretreated as instructions.  PuraMatrix (BD Biosciences) is 
diluted to 0,8 mg/mL in cold PBS, vortexed and 250 µl added soon on each insert. After 30 min 
37°C CO2 the excess of Puramatrix coating solution is removed by gentle tapping of the insert and a 
volume of FGM medium, enough to left the insert dish hydrated until next cell seeding, is placed in 
the lower chamber of cell culture plate. 5* 10
5 
NHLF are seeded on the top of the insert in 75 µl of 
FGM2 medium, then the insert is incubated for 1h at 37°C 5% CO2 to settle the cells. Afterwards 
the seeded inserts are flooded with FGM2 and culture medium is refreshed every other day.  
7.6.2 Epithelial layer assembly 
The day before the epithelialization of the mesenchymal compartment (i.e. the NHLF culture) are 
coated with a thick gel of rat tail collagen type I. Covering medium is removed from the apical part 
of the insert and 180 µl of neutralized 2 mg/ml solution in DPBS Ca
2+
 Mg
2+
 are pipetted and left to 
polymerize for 1h. Coated inserts containing NHLFs are replaced in incubator with submerged 
conditions. NHBE are harvested from the flask, diluted in trypan blue solution and counted with 
hemocytometer. Cells with >80% viability are counted and seeded with a density of 11*10
5 
cells/cm
2
 in 200 µl of BEGM, incubating 1 h at 37°C 5% CO2,. Subsequently 500 µl of BEGM are 
pipetted to the top of the insert and the set 3D-culture is moved in incubator for 24h, leaving the 
medium contacting the above and below of the insert independently. The day after additional 
medium is added to the well until submerging the insert combined to the cells.  
On day 3, each tissue-insert is transferred in the inner chamber of a Falcon inserts 3.0 μm pore size. 
At that point they are poured in Deep-Well plate (Falcon) and lower chamber of the Falcon insert 
filled with PneumaCult-ALI maintenance medium, supplemented with Primocin 50 ug/mL. 
Cultures are maintained with weekly medium replacement. Optionally, from the beginning of the 
2
nd
 week, surfaces of the cultures are washed twice with warm DPBS to prevent excessive mucus 
accumulation. After 3 weeks of ALI-culture, our differentiated BE (Bronchial Equivalent) models 
are ready-to-use or directly fixed for morphological characterization. In our preliminary studies, we 
pre-emptively verified viability of the BEs, incubating them in Prestoblue reagent and reading 
signal after 2 hours of reaction.     
7.6.3 Triple co-cultures 
For the immunocompetent model (DC-BE), dendritic cells are included during the gel coating of the 
Alvetex surface, prior to NHBE seeding. MoDCs, resuspended 2*10
6
 /mL in their cytokines 
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supplemented medium, are embedded in the collagen I dilution solution and later seeded 1*10
5
 cells 
to each Alvetex insert surface. The coating is left hydrated for 24h with basal MoDC medium.  
For the stromal hybrid “sustained” model (MSC-BE), a total of 500000 UC-MSCs / NHLFs in ratio 
1:3 are seeded in Alvetex insert and cultured in MesenPro until the NHBE addition.  
Apart from those modifications, the culture follows the steps above.  
The lot number of the lung derived cells are shared during the assembly of 3D cultures when a 
comparison between dual- and triple-culture is needed. 
 
 
7.7 Morphological characterization 
7.7.1 Histology  
The samples are fixed O/N in 4% paraformaldehyde pH 7.6, cut in 2 equal halves along the sagittal 
plane and processed for paraffin embedding. Then 3/4-μm sections are cut with Leica RM2255 
microtome. Deparaffinized and re-hydrated histological sections are stained with Carazzi’s 
Hematoxylin (1min 20 sec) and eosin (13 min), finally dehydrated. Images are acquired by Leica 
DM5000B microscope. For AB/HE a primary staining step is done for 30 min with Alcian Blue 
8GS 1% pH 2.5 and surface of samples are not washed before fixation.  
7.7.2 Immunohistochemistry  
For immunohistochemistry deparaffinazed slides are pretreated with Cell Conditioning 1 
(Roche), .Polyclonal α-laminin is incubated 12h with addition of antibody block (Roche #760-4204). 
For the detection secondary Ab HRP conjugated is overlaid for 20min and ChromoMap DAB kit is 
used (Roche #760-159). Immunostainer station is Discovery Ultra (Ventana).. 
Figure 19  Cartoon representing tryple cell culture configurations 
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7.7.3 Frozen section preparation  
Samples previously fixed for at least 24 h in PF 4% are soaked (O/N, 4°C) in sucrose 15% and then 
in a sucrose 30% bath before to include them in O.C.T. compound. The sample is frozen in 10 min 
in cold isopentane baker and stored at -80 until is processed for cryosectioning. 10 μm or 20 μm 
sections are made using Leica CM1950 cryomicrotome, fixed on Superfrost slides with 
ethanol:methanol and are used for immunofluorescence staining.  
7.7.4 Whole-sample epifluorescence imaging 
Untouched and unwashed fixed samples are stained for qualitative mucus and cilia detection by 
conventional immunofluorescence. Fixing is in 4% paraformaldehyde for 4 hr. Inserts are rinsed 
with washing-buffer (PBS, 0.1% bovine serum albumin, 0.2% Triton X-100, and 0.05% Tween- 20), 
blocked with blocking buffer (washing buffer 10% goat serum) then stained with primary 
antibodies, diluted in blocking buffer, at 4°C O/N with gentle shaking. Primary antibodies used for 
this specific assay are anti-MUC5AC (Mouse IgG1, Clone 45M1) and anti-α Tubulin, (Mouse 
IgG2b, clone 6-11B-1). Fluorescent conjugated secondary antibodies are used 1:200 in blocking 
buffer. Nuclei as well scaffolds are counterstained with Hoechst 3442 (1:10000). After final washes 
the samples are stored in PBS protected from the light at 4°C. Overlapping tiled images are 
acquired through Axiovert-200 microscope (Zeiss) equipped with a motorized stage and Orca-ER-
1394 camera (Hamamatsu), in AxioVision suite coupled to MosaiX module.  
7.7.5 Immunofluorescence on cut samples and cryosections 
ECM deposition by NHLF cultured in 3D culture was assessed with indirect immunofluorescence 
detection of fibronectin or collagen type I. Alvetex insert containing 1*10
6
 NHLF, were cultured for 
5-7 days in FGM2 medium, then fixed in PBS 2 % PF for 15 min. Antibody blocking solution ends 
with primary Ab 1:400 dilution in PBS 1% BSA is incubated for 1h, RT and gentle shaking. 
Secondary antibody Alexa-conjugated are used for the detection. Confocal microscopy equipment is 
a LSM710 system (ZEISS). For immunofluorescence broad analysis washed intact samples are 
fixed in PF 4% for almost 12 h, while for mucin detection some samples are alternatively fixed in 
cold Acetone/ Methanol solution for 10 min. Samples are then cut in different parts and washed 
twice in PBS. PF-fixed samples are also incubated 15 min in permeabilizing solution containing 
PBS 1% Triton x-100. Non-specific binding is blocked incubating samples for 45 min in cell culture 
plate wells with PBS 10% goat serum, 3% BSA, 0,1% triton. Antibody dilution buffer is PBS 1% 
BSA. Primary antibodies are diluted 1:250 and left O/N at 4°C with gentle rocking. The day next 
species are washed twice for 5 min with gentle agitation. Alexafluor conjugated secondary 
antibodies such as phalloidin are incubated for 1 h at RT and with rocking. After 5’ of staining with 
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Hoechst 33342 (1:10000) or DAPI in PBS the samples are washed in copious PBS then visualized 
under confocal microscope.  
For cryosections staining the slides are rehydrated with PBS, following a blocking step of 30 min. 
After 1 wash in PBS BSA 1%, primary antibodies are diluted in PBS 0,1% Triton and let to cover 
the slide for 1 h RT. After 3 quick wash, samples are exposed to matching Alexafluor secondary 
antibodies (or phalloidin) for 30 min prior to 2 wash in PBS and final counterstain with Hoechst -
33342. Finally samples are washed and mounted in Antifade Reagent. Acquisition, depending from 
the target, is performed through Axiobserver or LSM710 (Zeiss) platforms.  
7.7.6 Electron Microscopy 
Samples, eventually divided, are fixed in sodium cacodylate buffer 0,1M containing 2,5% 
glutaraldehyde and 2.5 % paraformaldehyde and stored at 4°C O/N. Samples were washed in the 
same buffer and then post-fixed in 1% OsO4 in 0.1 M cacodylate buffer pH 7.2 for 1 hour at room 
temperature and then washed again in the same buffer. Specimens were dehydrated in a graded 
ethanol series. They were then dried by the critical point method using CO2 in a Balzers Union CPD 
020, sputter-coated with gold in a Balzers MED 010 unit. The observation was made by a JEOL 
JSM 6010LA electron microscope. 
For Transmission Electron Microscopy (TEM), samples were fixed and dehydrated as described 
above and embedded in LRWhite resin (Multilab Supplies, Surrey, England). The resin was 
polymerised in tightly capped gelatine capsules for 48 h at 50°C. Thin sections were cut with 
Reichert Ultracut and LKB Nova ultramicrotomes using a diamond knife, collected on copper grids, 
stained with uranyl acetate and lead citrate, and observed with a JEOL 1200 EX II electron 
microscope. Micrographs were acquired by the Olympus SIS VELETA CCD camera equipped the 
iTEM software.  
7.8 Flow cytometry 
 For IL-10 screening samples are permeabilized antibodies  are incubated in BD 
Cytofix/Cytoperm™ buffer. PE-Mouse α-Human CD1a is used according to the datasheet and diluted 
in PBS. Flow cytometry reading is performed using Canto II (BD Biosciences). Data analysis was 
performed with FlowJo software (Tree Star). Cell gate is defined by FSC-SSC parameters to 
exclude debris or by Live/Dead fixable staining (molecular probe) to exclude not viable cells.   
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7.9 Cytokines Profiling  
To measure cytokine content produced by cells, the co-cultures media before and after ALI period 
were collected, centrifuged 1 min at 10000 rpm and soon stored at -80°C. Thawed undiluted media 
from biological triplicates are tested by Bio-Plex Pro™ Human Cytokine 27-plex, based on luminex 
technology, according to the supplier protocol. BEGM and Pneumacult-ALI reference wells values 
are used as threshold and also to normalize the different media condition between initial and 
concluded co-cultures. Media collected by cultures performed in different experimental conditions 
are considered to weigh good reproducibility of the data [data not shown], but excluded from the 
comparative analysis dataset. 1:100 and 1:1000 dilutions of media in DPBS are also tested to 
manage with the detection range. The plate is measured at the Bio-Plex array reader. Bio-Plex 
Manager software is used for data analysis. 
7.10 Infectability test 
NTHi 176 strain is cultured on chocolate plates O/N, 37°C, 5% CO2. Single colonies are picked up 
and bacteria are inoculated in BHI medium supplemented with NAD 2 ug/mL and haemin 10ug/mL. 
The liquid culture is incubated in rotary shaker, 37°C, until 0.4 OD (Abs 600nm) is reached. 
Pellected bacteria in exponential phase are resuspended in PneumaCult ALI maintenance medium 
without antibiotics. BE, starved for 1 day, are moved to a 12-well cell culture plate, with basal 
chamber only filled. After multiple washes of the BE, dissolved bacteria are pipetted atop BE and 
let to attach for 2 h, 37°C 5% CO
2
. Non-adherent bacteria are collected by several apical washes, 
before all the treated BE return to the incubator. After 24 h of infection, 1*10labeled PBMC are 
added in the basal chamber of each BE, suspended in fresh PneumaCult-ALI at the concentration of 
0,5*10
6
 /mL. After 16h and 32h the samples are fixed in PF 4% for 2 infection time-points. Samples 
are cryosectioned and analyzed by immunofluorescence. Negative controls of recruitment of 
PBMCs consist in pairs of BE uninfected, where there could be limited cells migration not induced 
by bacteria.  
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7.11 Antibody list 
Name Code Dilution 
α -β tubulin IV T7941 Sigma  1/250 
α-Laminin  T9393 Sigma 1/25 
α-collagen I Ab34710 Abcam  1:400 
α- MUC5AC MAB 2011 Millipore 1:250 
α-SCGB1A1 SAB2102083 Sigma 1:1000 
α-CK5 MAB3224 Millipore 1:250 
α-ZO1 Invitrogen 40-2200 1:125 
UltraMap anti rabbit HRP 760-4315 Roche TDS 
α-NGFR  Ab8874 Abcam 1:500 
PE- α- CD1a (clone HI149) (eBioscience) TDS 
FITC- α –IL-10  (clone JES3-9D7) (Invitrogen) 1:20 
MODCdifferentiation 
inspector 
130-093-567 TDS 
α-p63 ab735 Abcam 1:100 
α-ITGα6 ab20142 1:200 
α-CD45 clone HI30, Invitrogen  1:50 
 
 
7.12 Statistics 
Unpaired t-student is used for cytokines levels column comparison. Alternatively, for differentially 
expression between groups, one-way anova analisys is performed. P-values <0,05 will be 
considered significative. 
Table 2 Primary α-human antibodies used in this study. Different clones are cited in paragraphs when 
used.  
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8 Results 
8.1 Cell culture optimization and characterization 
The comparison between m1 and m2 for NHBEs cultured airlift on transwells resulted in a better 
expression of differentiation markers when using PneumaCult-ALI, evident at morphological level 
by SEM (not reported here) and immunofluorescence. In 3 weeks both m1- and m2- NHBEs were 
organized in a tight layer of cells characterized by ZO1 expression, while m2-fed cultures 
developed longer cilia (average length is 10 μm) and a higher number of GCs (MUC5AC+)( Figure 
21).  
Adipogenic differentiation of MSCs cultured in 2D or in 3D was confirmed by immunofluorescence 
staining for fat-producing cells. Neutral lipids vacuoles were not detected in control MesenPro 
samples. The number of positive vacuolated cells was higher in 3D culture than the 2D. Some of 
lipid-droplet-filled cells were differentiated along with the adipose lineage since the adypocite 
specific marker FABP4 was expressed (Figure 20).  
MSC/NHLF co-cultures revealed that both media are compatible with NHLFs and MSCs viability 
in vitro. NHLFs growth rate was augmented when they were cultured in FGM2 medium respect to 
MesenPro medium. FGM2 resulted to be suitable also for MSCs expansion [data not shown]. Since 
MesenPro is designed to maintain MSC multipotential characteristics and considering the 
proliferation grade among the different combinations of the co-cultures established, we decided to 
use MesenPro as culture medium for the MSC-BE, considering that this would not have induced an 
aberrant phenotype in MSCs profile. 
6-days cultured MoDC strongly downregulated the surface expression of the monocyte marker 
CD14, with only 10% of the cells still expressing this marker. At least 80% of the cells analyzed 
were positive for CD209, also known as DC-SIGN since it is a specific marker of in vitro generated 
dendritic cells. Cells expressing CD83, costimulatory factor, maturation marker were restricted to 
nearly 5% of the total attesting the immature dendritic phenotype of MoDC used for the DC-BE. 
CD1a positivity was detected for about 80% of the cells in accordance with the expected 
differentiation protocol (resumed results in Figure 22). 
Fluorescence labeling of PBMCs was checked before the cells were included within the BE. 
PMBCs were also screened for viability and were all viable after 24 hour of culture in PneumaCult-
ALI.  
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Figure 21 Pneumacult medium is superior for ALI 
differentiation of NHBEs. Increased ZO1 staining (b) 
and cilia numbers (d) than in B-ALI medium (a) (c) 
were obtained.  
Cilia length (e) and GCs staining confirmed complete 
differentiation towards mucociliary phenotype.  
 
b 
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a 
a b 
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Figure 20 Tryple culture 
characterization. MoDCs developed 
classical dendrites after 6 days of 
culture (a). MSCs retain their 
multipotency in alvetex scaffold: 
expression of FABP4 in green (b) 
and lipid neutral stain in red (C). 
40x original magnification. 
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8.2 Morphological characterization of the model 
8.2.1  Histological appearance  
HE single staining or combined with AB, performed on paraffin sections, provided a detailed 
picture of cell distribution and ideally properly localization within the BE template. Eosin staining 
highlighted the collagen coating that separates NHBEs from the scaffold. Collagen layer made with 
lower volumes of coating solution resulted in NHBEs entry into the scaffold [data not shown] and 
loss of polarity/differentiation. NHBEs grown within the 3D model were in contact with the 
collagen gel and differentiated into a pseudostratified, sometimes multilayered, epithelium, while 
the same cells grown on transwells originated a layer of cuboidal and not columnar cells (Figure 23).   
AB/HE staining allowed the clear detection of the mucus layer and of mucus-producing cells at the 
same time in all processed samples (Figure 23). Observations of the basic BE model and derived 
modifications indicated that the levels of produced mucus was in line with in vivo evidences. GCs 
number and localization were indicative of a good metabolic activity and differentiation grade of 
the epithelium. Furthermore mucus level was influenced by stromal cells presence (Figure 24). 
Indeed an increased number of NHLFs in the BE caused the formation of mucus boil reservoirs 
(data not shown), that disappeared when the stromal cell number was reduced or if the model was 
periodically washed as in the working protocol. Notably, also MSCs addition resulted in an 
increased GCs number (Figure 24, Figure 25). Considering the fact that the technical processing of 
samples affects the stability of the mucus layer, it was difficult to precisely compare different 
histological preparations even though AB
 
staining clearly indicated that the thickness of the layer 
was significantly enhanced in 3D conditions respect to standard transwell model (Figure 23). We 
never detected histological signs of squamous or basal metaplasia. 
 
 
C
D
1
a
 
Figure 22 MoDC FACs staining confirms the immature phenotype and CD1a positivity. In the third panel 
blue dots represent an unstained control sample.   
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Figure 23 HE staining of BE compared to transwell culture (a). AB-HE (b, c, d) to detect 
acidic mucins and GCs. 
2D 
Figure 24 AB-HE staining acidic mucin comparison on DC-BE(a), BE(b), MSC-BE. 40X original 
magnification.  
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8.2.2 Mucociliary phenotype in vitro mirroring  
Confocal microscopy analysis confirmed the morphological phenotype of the epithelium 
characterized by histology and SEM. Importantly this technique allowed us to distinguish the level 
of differentiation by staining mature cells trough a specific marker. Ciliated cells stained for 
acetylated tubulin coupled to a cell membrane marker, phalloidin, allowed the detection of 
epithelial areas covered with cilia, (Figure 25). We were also able to identify single GCs via 
MUC5AC staining. 
By the use of the MosaiX scanning software we were able to compare CCs and GCs phenotype on 
the whole insert. The results (Figure 31) showed that the introduction of MSC did not impaired full 
epithelial differentiation and that there were no differences in the mucus layer between the BE and 
MSC-BE.  
According to SEM analysis NHBEs grown in 3D conditions fully differentiated into a mucociliary 
epithelium (Figure 27). Indeed the superficial layer of the BE appeared as a thick carpet of cilia 
somethimes embedded into mucus patches. Depending on mucus distribution on the surface cilia 
were sometimes stitched together.  We rarely detected craters with amount of mucus gushing out 
the underlying cells (Figure 27, c). We also observed cells without cilia and microvilli. Overall we 
do not detected appreciable intra- e inter-variability between the different BE models assembled 
(dual or triple culture).  
TEM ultrastructural analysis of the different cells confirmed the nature of CCs and GCs. GCs 
granules and cilia structure are showed in micro -scale in Figure 28. 
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Figure 25 Confocal analysis of BE model: GCs (a) and CCs (b) are showed in green. Cilia distributed 
along the epithelium are showed in white (c) 
Figure 26 Mucociliary phenotype in triple cultures: DC-BE showed zone poorer in cilia, MSC-BE a small 
increase in GCs 
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Figure 27 SEM characterization of BEs. General top view of BE (b) and increasing magnifications of CCs 
rich area (a). Differences in mucus patches (c) between weekly washed (right panels) and not washed BE 
(left panels). NHLFs and putative culture microvesicles (d).    
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8.2.3 Stromal niche formation 
To verify that a 3D environment similar to lamina propria is formed by the fibroblasts to better 
accommodate and influence NHBE in the BE construct, we assessed the deposition nearby the cells 
and the scaffolds of some key components of ECM, such as fibronectin and collagen type I. A 
dense mesh of fibronectin was formed close to the cells and the fibrillary structures fitted in free 
space of the scaffold (Figure 31). Collagen I staining is sparsely distributed with a punctate location 
at the term of fibroblast cells (Figure 30). For laminin staining we cross-refer the results in the next 
paragraph. From the histological analysis we observed on the bottom of the scaffold a cell sheet 
made of NHLFs, that reduce its thickness if ALI - BE culture is not supported by transwell 
membrane. TEM images showed fibroblasts settled in the scaffold close to plastic material. 
  
Figure 28 TEM analysis of BE: the nucleus of the GC is at the base of the cell and low-dense granules appear 
within the cytoplasm (a); basal bodies and microvilli are evident on the apical part of a CC. 
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Figure 29 Semi-quantitave analysis by MosaiX reconstruction. Nuclei and scaffold (blue), CCs (red) and 
mucus (green) staining in BE and MSC-BE. Images are representative results of 3 samples. 
Figure 30 Z-stack 3D rendering of collagen I and fibronectin deposition in NHLFs 3D culture. Top and 
bottom view. F-actin (green) and DAPI (blue 
Figure 31 NHLFs cultured in alvetex scaffolds are able to produce ECM as fibronectin (red channel) in a 
physiological 3D spatial organization. 40x original magnification.  
BE 
Col-I Fn
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8.3 Barrier function 
The integrity of the epithelial sheet is indispensable if considering the epithelium a physical barrier 
against pathogens colonizing the human respiratory tract and typically requires the establishment of  
tight junctions (TJs) that seal together the epithelial cells forming the barrier. Zonula occludens 
marker (ZO-1) is generally present when TJs are well formed within a functional epithelial barrier. 
In the 3D-BEM ZO-1 properly delineated inter-cellular contour at the apical side of the NHBE layer. 
To evaluate the formation during the 3D culture of structural key components of the BMe, we 
searched for the deposition of ECM proteins within the model. In particular, by fluorescent and IHC 
analysis, we observed a thick and uninterrupted layer of laminin , the major component of BMe in 
vivo, just within the collagen coating between the 2 compartments at the bottom of the epithelium. 
While immunofluorescence on cryosections clearly showed this line of laminin at the epithelial-
mesenchymal interface, the staining was weakly extended to underlying epithelial cells contours 
and at their BL. In addition a strong laminin deposition close to fibroblasts was visible. The same 
analysis of NHBEs differentiated on transwell indicated that the laminin signal was scattered 
throughout the epithelium. Isotype control staining was confined to unspecific signal (probably 
mucus residues) on some areas of the sections (Figure 33). In addition we detected positive signals 
for ITGα6, BC marker, receptor for laminin and main component of the hemidesmosomes (Figure 
39  ). Optical microscope observations during the culture period disclosed that most of the MoDCs 
included in forming D-BEs were lost within the first days of ALI. The presence of the resting 
MoDCs was assessed by CD45 specific immunostaining.  
  
  
Figure 32 ZO1 (green) located at the AP of NHBEs in BE model indicated TJs formation. F-actin for 
cellular contours (red). DAPI counterstain nuclei (blue). Z-stack of 30 optical sections. On the right MoDC 
labeled by CD45 staining in green 
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8.4 Tissue renewal 
The investigation about the detection of potential homeostasis and repairing mediator cells required 
to work with cryosections, where all the cells of the epithelium can easily reach the antibodies. 
Firstly the persistence of progenitor cells in the differentiated epithelium, best candidate as 
homeostasis driver, was wondered. A cytoplasmic positive staining for CK5 highlighted, in all BE 
types, the layer of cells attached to the coating (Figure 36). CK5 (type II keratin) data confirmed 
again the presence of BMe equivalent and the presence of a basal layer of cuboidal cells expressing 
BCs marker. We investigated also the expression of CK14 (type I keratin), often assembled in pair 
with CK5, in complex epithelia [97]. The distribution of CK14+ cells did not follow a straight 
orientation compared to CK5 pattern that was almost parallel to the coating. Furthermore we 
monitored the nuclear expression of p63, basal cell progenitor marker, in which cells adjacent to 
collagen coating. Similarly to CK5 distribution we detected only fluorescent nuclei present in the 
lower part of the epithelium. To verify that BCs exist within this layer, we performed dual 
immunofluorescence studies. We just found small clusters expressing p63 that co-localized with 
CK14
+( 
Figure 39). The second transcription factor that we showed is located, resulting with a 
Figure 33 Laminin IHC suggested the formation of a basement membrane co-localized with the collagen 
coating. Isotype control is shown in the lower panels. 
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strong intensity, in the same considered group of cells CK5
+
, is NGFR, whose expression pattern 
that decreases until it disappears in the upper layer (Figure 39  ). We did not see any AQP3 staining 
in the epithelium produced in 3D in vitro conditions. 
Since NHBEs were isolated from both human tracheal and bronchial biopsies, we also wanted to 
check another set of cells able to participate in healing and regeneration, the Club cell.  For this 
reason we used antibodies directed against CC10 protein (murine CCSP), specific protein produced 
by Club Cells. In cryosections we better verify that CC10 labeled cells are a distinct staining from 
the one belonged to p63 or CK5 population, and that the staining cover both cytoplasm of these 
putative Club cells and mucus residues near them. Dual not competitive immunofluorescence for 
CC10 and MUC5AC on uncut samples revealed that although there is preferential staining of only 
one marker by the secretory cells there are few double positive cells.   
  
Figure 34 Sequentially in panels:  ClCs detection in upper layer of the epithelium (red). GCs(green) (Cl.C 
(red) and resting cells (gray) triple staining; last panel showed cell double positive for MUC5AC and CC-
10 proteins, suggesting linkage between the 2 GCs and ClCs differentiation.   
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Figure 38 Dual staining for laminin 
(red) and ITGa6 (green) interacting 
each other to supply a BMe 
Figure 36 Comparison between p63+ BCs(green signal) and CK14+ cells (red signal). DAPI (blue) and 
actin staining 
 
Figure 35 CK5 marked in green the 
cytoplasm of BCs in a similar 
section. Hoechst 32442 (blue) for 
nuclei and trasmitted light signal 
(red) as counterstain.  
 
Figure 37   BCs dual staining for 
NGFR(red) and CK5 (green). DAPI 
for nuclei in blue. 
Figure 39  NGFR high-positivity 
(red) at the bottom epithelial cells 
and ITGα6 staining (green) lining 
the coating (detached in this 
cryosection). 
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8.5 Secretion profile 
Quantification of the content of the cytokines released in the medium by three types of BE, showed 
a marked modification in the cytokines profiling between pre-ALI and final culture levels. Among 
our panel, IL5 was completely undetected; instead IL17 is not produced by cells. IL9 was discarded 
by statistics, while GM-CSF data-table was empirically inconsistent considering the relation 
between its dilution tests. Regarding IL2 only traces were detected in ALI D-BEs. Final plots and 
comments were derived from undiluted samples analysis, in which we detected all the resting 
cytokines included in the tester kit.  
About the proper GFs production, a related increase is observable during the ALI phase; we noted 
that all BEs secreted more VEGF and G-CSF and, at the same time, they consumed bFGF. PDGF is 
slowly produced without fold increase between starting and final cultures. 
The chemokines panel is more assorted. IL-4, IL-13, IL-15, MIP-1α and MIP-1β display lowest 
concentrations in the medium, staying in the pg/mL range. The level of IL-1β is minor of 
approximately 40X times in contrast to the related anti-inflammatory agonist IL-1ra. In the middle 
range of the observed concentrations we noted IL-10, TNF-α, IL-7, RANTES, IFN-γ, IL-12p70, 
with the latter one slightly reaching 1 ng/mL. We attested higher levels in secretion of MCP-1a, 
eotaxin, IP-10, IL-8, IL-6. Few cytokines are differentially expressed in the final conditions 
comparing the 3 BEs configurations (Figure 42), while significative differences from the dual 
culture belonged to the DC-BE model.   
 
Figure 40 Cytokine production and released levels in culture media by BE before ALI-phase (red line) and 
at the end (blu line) of the differentiation protocol.  
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8.6 NTHi infection 
For its first adhesion step, NTHi seemed to have a preference for CCs. We found on cryosections 
diverse cilia not bound to the cell surfaces, but dispersed in the mucus. Isolated bacteria are 
internalized in some epithelial cells, while more are located paracellular. A lot of bacteria reside in 
stromal layer, sometimes grouped especially in the bottom of the scaffold, where fibroblasts 
contacted directly the medium. In the stromal part they are linked to the ECM. Our NTHi-serum 
recognized also small particles not detectable in uninfected samples. These results are summarized 
in Figure 43. Finally we did not retrieve fluorescent signal by any PBMC in thick cryosections, 
neither improving the detection using CD45-FITC antibody. 
.  
 
Figure 41 Cytokines differentially secreted because the existence of DCs in the model.   
Figure 42 Cytokines differentially secreted between BE and its modified versions 
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Figure 43 Widefield stack (a,b) and confocal single plane (c,d) fluorescence analysis of BEs infected 
cryosections at late time-point. NTHi (red) was found in the mucus layer (c), inside epithelium(a), close to 
stromal niche (b) and able to cross all the thickness of the model (d). F-actin (green) and DAPI (blue) 
delineates the eukaryotic cells.  
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9 Discussion 
We developed a 3D in vitro cell culture aiming at reconstructing the human tracheobronchial tract 
in which will be feasible to test essential parameters of the response to vaccines. Its physical 
dimensions and organization made them similar in handling to already in vitro tools (like transwell) 
conventionally used for the same goal. Although it is laborsome, is also a relatively inexpensive 
approach.  
The ultimate goal would be the realization of a system able to answer specific scientific questions 
by selecting its components (i.e. the addition of a specific cell subset), thanks to the modular setting 
of the system. Previous references showed that MRC5 fibroblastoid cell line did not adequately 
recapitulated the niche favoring the alveolar differentiation [77], instead VE10 epithelial cells 
branched in co-culture with endothelial cells because most probably they derived and mimic the 
features of the native BCs. Here the choice of using in our model only primary cells derived from 
normal lung, the native tissue we want to reproduce in vitro.  
The 3D model owns a stromal compartment consisted of fibroblastic cells. While a porous 
polystyrene sponge provided just a physical requirement allowing the cells to assemble in a more 
relevant spatial distribution, we left the lung cells themselves free to reconstruct their acellular 
niche. Indeed puramatrix coating is just non-protein film and the fibroblasts synthetized ECM such 
us fibronectin, the “master assembler”, and collagen type I, the most abundant matrix in the lung. 
Abundant fibronectin supposes the formation of bridges between cell surface receptor like integrins 
and other ECM component as collagen type I. In one of the triple culture we set up we wanted to 
enrich that niche adding UC-MSCs. The choice of UC-MSCs [98]–[100] derived from a further 
characterization and dependability in comparison to commercially available Lu-MSCs. In addition 
it is reported a superior cell biological properties such as improved proliferative capacity and 
greater differentiation potential of MSC from birth-associated tissues over BM-MSC[101]. 
Extraembryonic MSCs senesced later and they are biologically closer to ESCs[98]. We bring the 
possibility that this cell type could confer a supplementary protective role in the context of infection 
and intoxication, sustaining in vivo evidences (listed in the introduction chapter) in which MSCs 
improved survival or enhanced bacterial clearance. MSCs also can function as fibroblast in the 
reconstruction of engineered skin [102]. 
The BE we “grew” in vitro is voluntary based on ALI traditional protocol to induce physiological 
and proven differentiation of lung epithelial cells. Certainly ALI means direct oxygen availability 
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for an epithelium naturally in contact with fresh air. In addition the medium we used in ALI phase 
is BPE-free, so the air exposure is more important condition for ciliogenesis [68]. SEM and 
confocal microscopy were used as favored techniques in order to improve the result and delete 
counterproductive conditions during the progress of the model development. From this couple of 
methods we gained a top view of a carpet of motile cilia covering one side of the BEs, as well the 
preeminent evidence of our success to differentiate NHBEs. Not the entire surface results planar,  
firstly because  there is a different height of the stratified layers, secondly the discrepancy is due to 
the collagen coating that histology confirmed to have small differences in thickness over the sample. 
The histological sections staining revealed the content of secretory cells and mucus thickness, while 
specific immunofluorescence and HE/AB staining confirmed the presence of GCs producing 
MUC5AC. Occasionally mucus cysts accumulated in the epithelium, without affecting 
differentiation of surrounding cells, as effect of fibroblast density and mucus accretion. Since there 
is a not natural removal of mucus from the model those cysts probably appear inside the epithelial 
layer because the collagen coating prevents the access to the lower part, however obstructed by the 
scaffold presence. Although daily washes of the pseudotissues were performed to mimic normal 
mucociliary clearance, establishing a more physiological removal for the mucins produced in these 
tissues would be more desirable. MSC-BEs seemed to push the NHBEs toward a more secretory 
phenotype, with more GCs[96], with mucus production almost equal to BEs (by Mosaix data) or 
either superior (by AB/HE ). Additional experiments should clarify this correlation.   
The barrier function is crucial against unwanted substances in breathing air in vivo and it is not only 
fulfilled by the epithelial cells but also by the basement membrane in vivo. Laminin is a non-
collagen protein mostly found in basal lamina, working to define this barrier. NHBEs are known to 
produce lamininV, the isoform responsible for the binding to integrin α6β4, important event during 
the in vivo formation of the basement membrane. In our model we use collagen I gel as coating to 
provide a low-stiffness and continuous surface to the adhesive NHBEs. As IHC and IF confirmed, 
under the bottom series of NHBEs, laminin protein is deposited drenching the coating. We could 
state that the NHBEs in our model, together with NHLFs, synergistically secreted the laminin, 
supporting the Kobayashi’s idea that cocultured fibroblasts sustain the assembling of an in vitro 
substitute for the natural basement membrane. At the same time the merge with ITGα6, signal 
found close to basal cells - coating area, suggests the formation of hemidesmosome.    
Our analysis demonstrated our model can hold potential regenerative mechanisms. Cell homeostasis, 
tissue repair, and cell turnover vary according the different organs. For example, CCS of the trachea 
and bronchi have half-lives of 6 months and 17 months, respectively [28]. Unperturbed adult lung is 
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almost quiescent, but is considered having a facultative regenerative capacity. The respiratory 
system could respond to injury and insults to repopulate lost cells by inducing proliferation, 
activating stem cells or progenitor populations, promoting differentiation, or by re-entering the cell 
cycle. Here we demonstrated the cellular system we developed contains cells in theory able to 
remodel the airway epithelium, BCs and Club cells. p63 is a p53-homologous nuclear protein that 
plays a critical role in regulation of stem cell commitment in several epithelia. CK5 is specifically 
expressed in cells usually undergo transient proliferation and showing multipotent differentiation 
after injury. p63
+
 CK5
+
 are BCs present in the pseudostratified airway in vivo and are bona fide 
progenitor cells that exist in our model. Also we detected CK14
+
 cells, a subset of BCs that increase 
transiently during repair[34]. One human surface marker is NGFR, whose labeling intensity 
gradually decreases towards the surface in large superficial cells. Fairly we did not observe on 
cryosections AQP3
+
 cells, while we hardly detected few of them by immunofluorescence in not 
well differentiated transwell samples [data not shown].  
We wanted to verify with explorative study the expression levels of cytokines produced by the BEs 
and their variants, as prior knowledge before undertaking a novel use of our model.  
We can just compared these levels with the ones measured in supernatants or apical washes of 
similar in vitro models containing HBEC, in particular in models used by Ren [21],Baddal 
(unpublished), Parker [103]. Values collected did not showed a content very dissimilar than the 
reference ranges, that, anyway, are very different each other according the culture conditions used.  
We confirmed previous reports that HBECs produce IL-6 and IL-8 [104]. The airway epithelium 
precisely produce IL-8 on a constitutive basis [21]  and upregulates this cytokine in response to 
bacterial exposure. IL-8 amount in basal media of BEs is second only to IL-6, the most abundant 
cytokine we detected in BEs that presented a level higher than all other reference values we 
considered from literature. We speculated this increase is due to NHLFs co-presence in culture. A 
lot of other chemoattractive molecules, such as IP-10, MCP-1a, RANTES, IL12-p70, G-CSF, IFNγ, 
IL1-ra are present in great valuable concentrations; some of them like are differentially expressed 
by BEs when MSCs or MoDCs are added. IL-1β, IL-9 and in particular IL-13 secretion correlated 
to a response to damaging stimuli [76]. IL-17A treatment was shown to biases in vitro BCs 
differentiation toward GCs. Just traces of these proinflammatory chemokines are listed in our 
chemokine output list, if they are detected. What we found in media is also an indication of which 
cytokines the co-culture consumed during the maturation of the model; bFGF is subtracted 
increasing the time of culture, very probably because the nutritional need by NHLFs. Regarding 
VEGF, in theory produced by fibroblasts and specifically by NHLFs [105],we did not infer a firm 
production by stromal cells, if it is considered that BEs levels were similar to NHBE reference 
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levels[106]. Anyway all the quantitative data generated are susceptible of discussion. First of all 
cytokines concentrations are dependent of cell number and culture conditions (2D vs 3D), thus they 
slightly differ from any reference sample to be compared. Thirdly we could not separate, neither 
experimentally, the quantitative contributions of the single cell types, because they are not simply 
cumulative each other. Furthermore, AP and BL of epithelial cells have directional responses in 
cytokine secretion implying that polarized HBECs can selectively or differentially secrete many 
cytokines in AP, e.g. in the case of an intrusive pathogen. Since we did not treat the apical surface 
of the models, we collected only basal media to avoid technical problem related to the density of 
apical washes, as well we are interested also in the stromal trophic function. 
Human lung DC characterization showed a phenotype and an endocytic capacity close to in vitro 
immature DCs. D-BEs indeed are prepared including immature MoDC.  DC consisted in a very 
motile populations, their trafficking to the lymph node and the recruitment to the different 
anatomical tracts of lung are influenced in nature by inflammation condition. We concluded with 
the verification that MoDCs faintly persist until the end of the 3 airlift weeks in D-BEs. No one of 
the immunocompetent model we cited admitted DCs entered the co-culture early and stay for 3 
weeks later. The migration to the lower part (and the final partial loss) is very likely an effect  
happened and already shown in similar 3D organotypic model [93].  
Infecting BEs with NTHi we noticed specific signs of ciliotoxicity, paracellular and transcellular 
transit, use of the host ECM niche. This agree with a putative model of NTHi pathogenesis. In our 
experimental set-up we did not observe a migration of PBMCs to the infected model. Among 
plausible explanations of the missing recruitment there are antigravity impediments, obstruction by 
the bottom NHLFs -sheet, without leaving out the possibility that granulocyte fraction could be 
involved in place of PBMCs. 
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10 Literature review  
10.1 C.difficile Toxins 
TcdA and TcdB (also, Tox A and ToxB) are homologous AB toxins, with 49% identity and 63% 
similarity. The proteins share a common large multi-domain structure, basically composed in a N-
terminal glucosyltransferase domain (GTD), a central translocation domain and a C-terminal region 
mediating receptor binding. TcdA (as TcdB) enter the cell by clathrin-mediated endocytosis. Once 
the toxins have been internalized, endosomal acidiﬁcation induces structural changes in the 
translocation domain exposing hydrophobic segments. Based on an auto-proteolytic step, just the 
catalytic domain is delivered across the endosomal membrane towards the cytosol. The enzymatic 
function of the toxins is carried out by a 63-kDa catalytic centre that acts on small GTPases 
involved in regulation of the cytoskeleton. Historically, cell-rounding and cell death are referred as 
the cytopathic effect and cytotoxic effect, respectively. Both toxins, also, may account for C. 
difficile opportunistic ability of colonizing the mucosa. Indeed Kasendra et al. showed that in 
particular ToxA-mediated subversion of cell polarity facilitates the exposure of preferential sites of 
bacterial binding to the mucosa [107].  Glucosylation of the GTPases prevents their interactions 
with multiple effectors and regulatory molecules and thereby prevents multiple Rho and Ras 
pathway signaling involved in cell cycle progression, cell-cell adhesion and maintenance of the 
cytoskeleton. ToxA and ToxB have been reported to cause death through a number of different 
mechanisms including apoptosis as well as necrosis. Inactivation of Rho GTPases by ToxA and 
ToxB results in the disruption of cell-cell junctions, contributing to an increased epithelial 
permeability.  
ToxA is comparable with ToxB in its modification of Rho family substrates, but TcdA only is 
capable of modifying Rap family GTPases [108]. The mechanisms by which ToxA and ToxB 
mediate inflammation involving activation of MAP kinase, NFκB and AP-1, and stimulation of IL-
8, occurred via two different Rho-dependent and -independent pathways [23] 
[109][108], [110] . 
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10.2 The intestinal epithelium 
The intestinal tract consists of two anatomically distinct organs: the small intestine (SI) and the 
colon. SI epithelial organization reflects its absorptive function, by the presence of finger-like 
structures called villi. The villi are surrounded by multiple invaginations, the crypts of Lieberkuhn. 
Luminal epithelial cells are exposed to physical, chemical, and biological insult and up to 1011 
epithelial cells can be lost in humans daily. New cells must be generated in order to compensate for 
high rate of cell death on the villi. Stem cell niche resides at the bottom of crypts and produce 
progenitors called transit-amplifying cells (TAC) that migrate upward toward the crypt/villus border 
and finally differentiate. Four types of mature cells present in the SI epithelium: enterocytes (EC), 
absorbing water and nutrients, Goblet cells (IGC), enteroendocrine cells (EE) and Paneth cells (PC) 
that secrete antibacterial substances (such as cryptdin). In contrast to SI, the colon has an epithelium 
with multiple crypts associated with a flat luminal surface, a high density of GCs and the absence of 
PCs. A specific niche enables the constant sustaining of the high cell turnover in the SI. A group of 
Intestinal stem (ISC) are located closely to PCs and it is surrounded by mesenchymal cells. PCs 
subset has a low-rate of renewal. They differentiate from secretory cell progenitors, located at the 
base of the TACs, which follow a downward migration to the crypt [111]. 
Figure 44 Protein structure and mechanism of action inside the cell  by C.difficile binary toxins. Source : 
Pruitt et al. 2012 [110] 
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10.3 Intestinal Stem Cells 
Two models of ISCs identity historically competed each other: the “+4 position” and the “stem cell 
zone” model.  Leblond’s Crypt Base Columnar (CBC) cells are the ISC candidate in the stem cell 
zone model.  Lgr5 is a the receptor for the Wnt-agonistic R-spondins and its expression in restricted 
in crypts. By lineage-tracing experiments, Baker et al. revealed exclusive expression of Lgr5 in 
cycling CBCs in SI, that were able to generate all epithelial lineages [112]. Lgr5
+
 is considered 
marker of ISC. PCs are an important constituent of the ISC niche; the self-renewal of ISCs are 
dependent on direct cell contact between ISC and Paneth cells [113]. The second category of ISCs 
is named “+4 cells” because of their average position (above PCs compartment) in the crypt. They 
were originally identified by Potten et al. as DNA label-retaining cells. There are not unique marker 
for +4 cells but a signature of 4 main putative antigens are reported. Bmi1 a member of Polycomb 
family with an essential role in maintaining chromatin silencing, is a not-selective marker 
predominantly expressed at +4 position in SI and are not seen elsewhere in the intestinal tract. 
Isolated Bmi1
+
 cells are Wnt-independent and minimally overlapping CBCs.  Currently the theory 
that more than one ISC type may coexist is emerging and supported [114]. This assumes a 
specialized niche environment in which SI use both the distinct ISC populations. In a cooperative 
model, the cycling CBCs are responsible for daily homeostasis, whereas more quiescent +4 cells 
can be activated during epithelial repair following injury.  Although their separate roles, 
independent studies showed the +4 markers are expressed by Lgr5
+
 CBCs. In addition Bmi1+ cells 
contribute to the repopulation of the LGR5+ in vitro e and in vivo bring evidence a complex interplay 
between the two cell-lineage. Are Bmi1
+
 and Lgr5
+
 truly independent ISC pools?  
Figure 45 CD24 and Lgr5+ distribution at the bottom of the crypts. Sources: Leushacke M, et al. 2014 
[128]Sato et al. 2011[111] 
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10.4 Gut organoid model 
Confident of Lgr5
+
 cells potency, Clevers’s group revealed murine crypts cultured in vitro in 3D 
environment form “organoids” which mimic the histological hierarchy recapitulating in vivo SI 
epithelium. Even though the ISCC [115] classified this epithelial cell culture as “enteroids”, we will 
like to name them with the term that the discovering authors continue to use. The organoids produce 
all mature cells with physiological localization and frequency patterns. They are composed of a 
central cyst structure, lined by villus-like epithelium and several surrounding budding structures. 
The basal side of the polarized cells is oriented toward the Matrigel, whereas secretion by PCs and 
GCs occurs toward the lumen formed by EC borders. ISCs and PCs reside at the bottom of the 
budding crypt-like domains. As cells divide and differentiate, they are conveyed along the walls of 
the crypt. Apoptotic cells are progressively shed into the lumen. The “ENR” combination of growth 
factors (EGF, noggin and R-spondin 1), simulating the pathway present at the level of the niche, is 
essential to maintain ISCs in vitro. Indeed crypt growth requires EGF and R-spondin, while it is the 
organoids passaging to require Noggin actually. It was demonstrated that, provided necessary 
instructory signals, also single Lgr5
+
 cells are sufficient to generate organoids in the absence of a 
mesenchymal niche[116].  Similarly Bmi1
+
 ISCs can generate clonally derived intestinal spheroids 
containing also Lgr5
+
 cells[117].  
The ENR cocktail is not adequate to sustain efficient in vitro propagation of a pure population of 
ISCs when they lose contact with PCs, actually an important source of various niche factors 
(Figure 46). The combination of CHIR and VPA, by activating Wnt pathways and suppressing 
secretory cell specification, maintains ISCs in an undifferentiated state and promote their self- 
renewal [113].  
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Figure 46Organoid culture rationale (d) and signaling(a) and GFs/compounds(b) involved in the 
maintenance in culture (a) of organoids and selecting pathways inducing different lineages.  Source: Sato 
and Clevers, 2013,[129] Yin et al. 2013[113] 
Figure 47 Organization of stem cell niche and effectors in the epithelial hoemostasis. Source: Barker 2013, 
[114][112] 
d 
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11 Methods 
11.1 Organoid culture 
The protocol is already described and adapted from Sato et al. 2013. The enteroid culture method 
was modified from Sato et al. Mouse proximal small intestine (∼10 cm) was excised, opened 
longitudinally, and washed with ice-cold PBS. The intestine was cut into small pieces (∼4- to 5-mm 
diameter) villi are removed by scraping and pieces are incubated in ice-cold PBS containing 2 mM 
EDTA for 30 min at 4°C. After being rinsed once with ice-cold PBS to remove EDTA, the 
intestinal fragments were resuspended four times in ice-cold DPBS 0,5 % BSA by repeated, 
vigorous pipetting, using a 10-ml pipette. Different fractions are collected in BSA coated tubes. The 
supernatant from selected fractions enriched in crypts is collected and passes through a 70-μm cell 
strainer to remove tissue fragments. Crypts in the strained solution are separated from suspended 
single cells by centrifugation (600 rpm, 1 min). The crypts pellet is resuspended with cold PBS, 
crypts number is counted at the optical microscope.  ToxA is eventually diluted  and incubated with 
crypts at this step, allowing the exposure of the toxin to the luminal part of the  developing 
organoids. 500 crypts are mixed with 50 µl of Matrigel (BD Bioscience) for plating in single well 
24-well cell culture plates. After polymerization of the Matrigel, culture medium composed of 
Advanced DMEM/ F12 (Gibco), supplemented with N2 and B27 supplements,  containing,  PS 
solution, hepes buffer, 500 ng/ml Rspondin1, 100 ng/ml noggin, and 50 ng/ml epidermal growth 
factor (EGF) was added and changed every 2–4 days. 
11.2 Optical microscopy 
Images acquisition of the samples was done using Olympus inverted microscope equipped with 
cooled color CCD and cellSense software.  
11.3 Crypts Viability Assay 
Crypts from wt or Lgr5-GFP
+
 mice are isolated as described for organoids culture. Freshly isolated 
crypts are incubated with ToxA/TcdA 1X or 50X sublytic amounts in medium for 30 min, at 37°C. 
Samples are incubated on ice, mechanically dissociated trough thin tip pipetting, then stained with 
L/D working solution or PI. Additionally α-CD24 staining is performed for 20 min. Fixed cells (by 
PF) are resuspended in tubes and analyzed. 
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11.4 Organoids viability 
Organoids treated with ToxA at the culture iniziation, are scraped from plates and harvested from 
the matrix by cell recovery solution incubation (BD). Dissociation is performed in a solution HBSS 
w/o Ca
+2
 and Mg
2+ 
supplemented with 0.3 U/ml Dispase (Corning), 0.8 U/ml DNase (Sigma), and 
10 μM Y-27632 (Sigma) for 30 min at 37°C. Live/dead staining is performed before prepare cell 
resuspension for flow cytometry analysis.  
11.5 Binding assay 
ToxA different preparation (called here “TcdA”) is conjugated with AlexaFluor-647 (Invitrogen 
Kit). TcdA-647 are maintained at 4°C (on ice also). Dissociated crypts are incubated as above. The 
reaction is stopped fixing 4% PF. Samples are washed twice in cold PBS. To do not affect viability 
and check the inactivation of the toxin by temperature we measure at the same time viability also of 
wt type ToxA treated cells. We incubate 50X [C] of ToxA for 20 min on ice, after they are washed 
and stained with L/D (or PI.). Eventually, cells were washed with 1% PBS/BSA and stained with 
CD24-APC antibody (clone M1/69 BioLegend). As negative control of specific binding we 
conjugated and used 647 conjugated BSA. Bound cells are considered in the cell gate and APC
+
. 
11.6 Statistics  
The descriptive statistical analysis was performed on Graphpad Prism version 5. Results are 
expressed as fold change of mean values. Each bar displaying SEM represents a duplicate or a  
triplicate samples. Data are analyzed with unpaired t-test or Mann-Whitney U test. Values were 
considered statistically significant if p<0.05. 
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12 Results 
12.1 Viability state of the intestinal epithelial cells 
Preliminary experiment showed ToxA treated organoids do not affect the growth of organoids, but 
cellular debris poured out from the epithelium compared to the control organoids. The toxin affect 
viability of organoids as assessed by flow cytometry live/dead staining. A higher concentrations 
(10X) did not increase significantly death in organoids (Figure 49).  When the toxin is incubated in 
the same manner but in contact with a crypts not destined to organoids formation, we saw a similar 
fold change difference in death in 10X [C] of toxin. The discrepancy between treated and untreated 
samples is persistent also in increasing toxin dose conditions (50X)(Figure 50). A similar 
comparable trend is led by different ToxA preparation that we called “TcdA”. A specific staining 
for CD24 designed a panel of cell specific death by this population as confirmed by loss of events in 
flow cytometer counting for the selected marker (Figure 51). In a different binding experiment 
(Figure 52) we wanted to incubate labeled fluorescent ToxA and TcdA at 4°C to look at the specific 
binding of some cell set (preliminary no loss of cells in this condition was checked by live/dead 
assay). This specificity was confirmed consisting in an average 15% of crypts preparations.  
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Figure 48 Untreated 4-days cultured organoids (above) and toxin treated organoids (below). Optical 
microscopy 20X orginal magnification  
Figure 49   Organoids cells death caused by 37°C intoxication reaction. 
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Figure 50 Crypts cells death caused by 37°C intoxication reaction. 
Figure 52 Toxin induced death is inactivated at 4°C (left graph). TcdA-647 selectively bound a cell 
group in crypts preparation (right graph).   
Figure 51 Loss and dead cell subset after 37°C toxin exposure 
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13 Discussion 
Using Clevers’s method to set up in vitro mini-guts, the investigation of C.difficile ToxA / TcdA on 
SI mucosa was proven to affect barrier function, confirming the classical role as well as recent 
discoveries about this toxin and it suggested role to facilitate bacterial colonization [107]. We also 
observed toxin-dependent cell death within the organoid model. The same toxicity was soon 
detectable after shorter incubation with a higher sub-lethal dose of the toxin. In our preliminary 
experiments on whole crypts preparations, the cytotoxic effect seemed to be associated with a 
decrease in a subset of cells expressing CD24, a marker highly associated to crypts resident cells.  
The organoid model develops all the major intestinal cell types, ISCs included, so during its culture 
has the possibility to repair acute damages. However an eventual protective or repairing mechanism 
is difficult to follow over-time. Alternative approach to organoids use could consist in the isolation 
of the different epithelial populations by FACS that should require a lot of starting material and a 
long protocol make it inconvenient to get viable intestinal cells for downstream experiments. In 
conclusion, precise milestones, such as selective cell binding studies, seemed necessary to be 
achieved prior to validate hypothesis on organoids.  
Moving towards a different framework in which ISC and PCs are enriched will be useful to detect 
early events of the cytotoxicity as specific cell binding and subsequent impairing epithelial 
regeneration. In this context, the direct use of crypts containing Lgr5-GFP
+
 will enable to identify 
the ISCs subset, otherwise rare.  CD24 staining on crypts is well characterized [118] and Lgr5-
GFP+ signal is stronger as well the one observable in vivo than in long-lived organoids. In addition 
tracking the toxin by specific antibodies or fluorescent conjugation may add the opportunity to 
study spatial modifications in tissue architecture and drive attention on cell-toxin contact 
significance. By validating specific cell type marker and tracing the toxin trough such methods we 
are intending to decipher the cellular target of a chief virulence factor of a re-emerging pathogen.  
Further optimized experiments might support the idea that this toxin is able to interfere in the 
epithelial gut homeostatic balance, suggesting a correlation with the early phase of the chronic 
pathogenicity.  
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CONCLUSION 
Scientists routinely work within the 3R's principles of ‘Reduction, Refinement and Replacement’ of 
animal experiments. Stressing on this approach, biomimetic in vitro tissue models of preclinical 
studies are highly desirable.  
Our knowledge of microbial pathogenesis is historically linked to aberrant in vitro models 
base on traditional cell culture. At the same time in vivo models derived results, however, can be 
transferred only partially to humans. We proposed a method to reconstruct a human respiratory 
mucosa in vitro. Despite of the need of a further characterization, the model that can be obtained 
provides a functional tool to be suitable in host-pathogen interactions studies. Similar to emerging 
commercially available ready to use products (Epiairway, MucilAIR) our protocol invite to 
establish an in-house platform to be superior in term of customizability, competitive ease of use and 
reduced costs.   
Aspects of vaccinology that might be impacted by our 3D airway model are:  
a) Measurement of immune-mediated bacterial clearance by antigen-specific antibodies. This 
application would be fundamental to identify bacterial targets that are really effective as vaccine 
candidates.  
b) Monitoring pathogens behavior at mucosal interfaces to determine the most efficacious strategies 
to hinder colonization. For example the evaluation of the capacity of specific antibodies to impair 
bacterial adhesion/biofilm formation would be an added value to vaccine candidate selection.  
c) Determination of the best vaccination strategy in order to obtain an effective response at the 
mucosal barrier. Indeed the plasticity of the model permits the addition of specific cellular subsets 
as tools to evaluate vaccination efficacy.  
d) Evaluation of the inflammatory response to vaccine components, including reactogenicity to 
LPS/LOS. 
In vitro relevant models would also be requested in alternative to complex in vivo derived 
data and because the lack of genetic tools to manipulate C. difficile. The intestine constitutes an 
excellent system for studying regeneration. The cell architecture of the SI draws attention because 
crypts and villi represent a repetitive multitasking unit to study tissue homeostasis. The intestinal 
niche is a critical component in governing stem cell behavior and crypts plasticity. Recent progress 
 CONCLUSION 
   
 
  
in the isolation of ISCs led to the creation of 3D cell models that include the entire villus-crypt 
axis.  SI murine organoid culture allows studying early phase of the infection at cellular levels, with 
a quick recover of the cell targets. This cell culture method could drastically improve the efficiency 
of GI translational medicine. We used organoids as well-performing tools to elucidate the overall 
effect of toxins on the homeostasis of gut epithelium. Unraveling ToxA cellular target among stem 
cell niche may represent a challenge to develop new treatment and prevention strategies for CDI, 
since the incidence and costs associated are making it a signiﬁcant public health alarm. 
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